0001493152-23-004324.txt : 20230210 0001493152-23-004324.hdr.sgml : 20230210 20230210170330 ACCESSION NUMBER: 0001493152-23-004324 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230210 DATE AS OF CHANGE: 20230210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Earth Science Tech, Inc. CENTRAL INDEX KEY: 0001538495 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454267181 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55000 FILM NUMBER: 23613186 BUSINESS ADDRESS: STREET 1: 8000 NW 31ST STREET, UNIT 19 CITY: DORAL STATE: FL ZIP: 33122 BUSINESS PHONE: (786) 375-7281 MAIL ADDRESS: STREET 1: 8000 NW 31ST STREET, UNIT 19 CITY: DORAL STATE: FL ZIP: 33122 FORMER COMPANY: FORMER CONFORMED NAME: Ultimate Novelty Sports Inc. DATE OF NAME CHANGE: 20111230 10-Q 1 form10-q.htm
0001538495 false --03-31 Q3 2023 0001538495 2022-04-01 2022-12-31 0001538495 2023-02-09 0001538495 2022-12-31 0001538495 2022-03-31 0001538495 ETST:AccruedSettlementTwoMember 2022-12-31 0001538495 ETST:AccruedSettlementTwoMember 2022-03-31 0001538495 ETST:ConvertibleNoteOneMember 2022-12-31 0001538495 ETST:ConvertibleNoteOneMember 2022-03-31 0001538495 ETST:ConvertibleNoteTwoMember 2022-12-31 0001538495 ETST:ConvertibleNoteTwoMember 2022-03-31 0001538495 ETST:ConvertibleNoteThreeMember 2022-12-31 0001538495 ETST:ConvertibleNoteThreeMember 2022-03-31 0001538495 ETST:AccruedSettlementOneMember 2022-12-31 0001538495 ETST:AccruedSettlementOneMember 2022-03-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-03-31 0001538495 ETST:PromissoryNoteGHSMember 2022-12-31 0001538495 ETST:PromissoryNoteGHSMember 2022-03-31 0001538495 ETST:ConvertibleNoteFourMember 2022-12-31 0001538495 ETST:ConvertibleNoteFourMember 2022-03-31 0001538495 2022-10-01 2022-12-31 0001538495 2021-10-01 2021-12-31 0001538495 2021-04-01 2021-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-10-01 2022-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2021-10-01 2021-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-04-01 2022-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2021-04-01 2021-12-31 0001538495 ETST:PromissoryNoteGHSMember 2022-10-01 2022-12-31 0001538495 ETST:PromissoryNoteGHSMember 2021-10-01 2021-12-31 0001538495 ETST:PromissoryNoteGHSMember 2022-04-01 2022-12-31 0001538495 ETST:PromissoryNoteGHSMember 2021-04-01 2021-12-31 0001538495 us-gaap:CommonStockMember 2021-09-30 0001538495 us-gaap:PreferredStockMember 2021-09-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001538495 us-gaap:RetainedEarningsMember 2021-09-30 0001538495 2021-09-30 0001538495 us-gaap:CommonStockMember 2021-12-31 0001538495 us-gaap:PreferredStockMember 2021-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001538495 us-gaap:RetainedEarningsMember 2021-12-31 0001538495 2021-12-31 0001538495 us-gaap:CommonStockMember 2022-03-31 0001538495 us-gaap:PreferredStockMember 2022-03-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001538495 us-gaap:RetainedEarningsMember 2022-03-31 0001538495 us-gaap:CommonStockMember 2022-06-30 0001538495 us-gaap:PreferredStockMember 2022-06-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001538495 us-gaap:RetainedEarningsMember 2022-06-30 0001538495 2022-06-30 0001538495 us-gaap:CommonStockMember 2022-09-30 0001538495 us-gaap:PreferredStockMember 2022-09-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001538495 us-gaap:RetainedEarningsMember 2022-09-30 0001538495 2022-09-30 0001538495 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001538495 us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001538495 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001538495 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001538495 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001538495 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001538495 2022-01-01 2022-03-31 0001538495 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001538495 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001538495 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001538495 2022-04-01 2022-06-30 0001538495 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001538495 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001538495 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001538495 2022-07-01 2022-09-30 0001538495 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001538495 us-gaap:PreferredStockMember 2022-10-01 2022-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001538495 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001538495 us-gaap:CommonStockMember 2022-12-31 0001538495 us-gaap:PreferredStockMember 2022-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001538495 us-gaap:RetainedEarningsMember 2022-12-31 0001538495 2021-03-31 0001538495 us-gaap:LeaseholdImprovementsMember 2022-04-01 2022-12-31 0001538495 ETST:SignageMember 2022-04-01 2022-12-31 0001538495 us-gaap:FurnitureAndFixturesMember 2022-04-01 2022-12-31 0001538495 us-gaap:ComputerEquipmentMember 2022-04-01 2022-12-31 0001538495 ETST:RxCompoundAndPeaksMember 2021-11-01 2021-11-03 0001538495 us-gaap:RestrictedStockMember 2022-10-01 2022-12-31 0001538495 us-gaap:RestrictedStockMember 2021-10-01 2021-12-31 0001538495 ETST:PurchaseAgreementMember 2022-11-08 0001538495 ETST:PurchaseAgreementMember 2022-11-07 2022-11-08 0001538495 ETST:PurchaseAgreementMember 2022-06-30 0001538495 srt:ChiefExecutiveOfficerMember 2022-12-31 0001538495 srt:ChiefFinancialOfficerMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended December 31, 2022

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number: 000-55000

 

EARTH SCIENCE TECH, INC.

(Exact name of registrant as specified in its charter)

 

Florida   80-0931484

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

8950 SW 74th CT

Suite 101

Miami, FL 33156

(Address of principal executive offices) (zip code)

 

(786) 375-7281

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock $0.001 par value   ETST   Over the Counter Bulletin Board

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer Accelerated filer
         
  Non-accelerated filer Smaller reporting company
         
  Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of February 9, 2023, there were 256,695,496 Common and 1,000,000 Preferred shares of the registrant’s stock outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
PART I. FINANCIAL INFORMATION  
     
ITEM 1. Financial Statements (Unaudited) F-1
  Balance Sheets as of December 31, 2022, and March 31, 2022 F-1
  Statements of Operations for the Nine Months Ended December 31, 2022, and 2021 F-2
  Statements of Changes in Shareholders Equity the Three Months Ended December 31, 2022 F-3
  Statements of Cash Flows for the Nine Months Ended December 31, 2022, and 2021 F-4
  Notes for the Financial Statements F-5-F-12
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 3
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk 10
ITEM 4. Controls and Procedures 10
     
PART II. OTHER INFORMATION  
     
ITEM 1. Legal Proceedings 11
ITEM 1A. Risk Factors 11
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 11
ITEM 3. Defaults Upon Senior Securities 11
ITEM 4. Mine Safety Disclosures 11
ITEM 5. Other Information 11
ITEM 6. Exhibits 12
     
SIGNATURES 13

 

2

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

Earth Science Tech, Inc. & Subsidiaries

Consolidated Balance Sheets

 

   December 31, 2022   March 31, 2022 
ASSETS          
Current Assets:          
Cash  $24,188   $26,942 
Accounts Receivable(net allowance of $0 and $101,404 respectively )  $   $ 
Prepaid expenses and other current assets        
Inventory        
Total current assets   24,188    26,942 
           
Other Assets:          
Due from RxCompound   397,382    25,000 
Prepaid Acquisition Costs   98,000    25,000 
Telemedicine Platform   17,806      
Total other assets   513,188    50,000 
Total Assets  $537,376   $76,942 
           
LIABILITIES AND STOCKHOLDERS EQUITY          
           
Current Liabilities:          
Accounts payable  $119,331   $202,270 
PPP Loan       31,750 
Accrued Settlement II   158,846     
Convertible Promissory Note I   220,000     
Convertible Note II   150,000     
Convertible Note III   200,000     
Loan Advance       50,000 
Revolving Promissory Note   250,000    50,000 
SBA EDIL Loan   102,956    106,800 
Accrued expenses   86,183    311,610 
Accrued settlement I       585,886 
Interest Payable Convertible Notes IV       83,475 
Interest Payable Promissory Note       14,429 
Convertible Notes IV       326,838 
Promissory Note       30,000 
SBA Payable   10,359      
Due to RxCompoundStore.com, LLC.   110,363    1,895 
Note Payable       27,500 
Note Payable Interest       344 
Notes Payable - related party       59,558 
           
Total current liabilities   1,408,038    1,882,355 
           
Commitments and contingencies   -    - 
           
Stockholders’ (Deficit) Equity:          
Common stock, par value $0.001 per share, 750,000,000 shares authorized; 257,964,406 and 53,851,966 shares issued and outstanding as of December 31, 2022 and March 31, 2022 respectively   257,966    53,853 
Preferred stock B par value $0.001 per share 1,000,000 authorized and outstanding as of December 31, 2022   1,000     
Additional paid-in capital   29,106164    28,264,452 
Accumulated deficit   (30,265,697)   (30,123,718)
Total stockholders’ (Deficit)Equity   (900,567)   (1,805,413)
Total Liabilities and Stockholders’ (Deficit) Equity  $537,376   $76,942 

 

F-1

 

 

Earth Science Tech, Inc. & Subsidiaries

Consolidated Statements of Operations

 

  

For the Three

Months Ended

December 31, 2022

  

For the Three

Months Ended

December 31, 2021

  

For the Six

Months Ended

December 31, 2022

  

For the Six

Months Ended

December 31, 2021

 
Revenue  $2,533   $3,997   $2,533   $13,942 
Cost of revenues   825    2,467    825    7,544 
Gross Profit   1,708    1,530    1,708    6,398 
                     
Operating Expenses:                    
                     
Compensation - officers   9,654    30,846    86,173    46,058 
Officer compensation stock           4,500     
General and administrative   5,599    61,526    161,540    99,035 
Professional fees   22,233    5,165    31,433    6,065 
Loss on disposal of assets               1,712 
Bad debt expense       4,944        4,944 
Marketing   4,200        4,200     
Litigation Expense           512,725     
Cost of legal proceedings   8,297        18,497    7,267 
Total operating expenses   49,983    102,481    819,068    165,081 
                     
Loss from operations   (48,275)   (100,951)   (817,360)   (158,683)
Other Income (Expenses)   166,037        724,062    3,408,930 
Other Income                    
Interest expense   (18,321)   (2,452)   (29,565)   (8,040)
Interest Expense-Convertible Notes IV       (9,289)       (32,203)
Interest Expense-Promissory Note       (1,361)       (4,068)
Note Payable Interest           (1,104)    
Interest SBA Loan   (977)   (995)   (5,929)   (1,995)
Total other income (expenses)   146,739    (14,097)   687,464    3,362,624 
                     
Net Profit/(Loss) before income taxes   98,464    (115,048)   (129,896)   3,203,941 
                     
Income taxes                
                     
Net Profit/(Loss)  $98,464  $(115,048)  $(129,896)  $3,203,941 

 

F-2

 

 

Earth Science Tech, Inc. & Subsidiaries

Consolidated Statements of Stockholders’ (Deficit) Equity

For Three Months Ended December 31, 2022 and 2021

 

Description  Shares   Amount   Shares   Amount   Capital   Deficit   Total 
   Common Stock   Preferred Stock   Additional Paid-in   Accumulated     
Description  Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance September 30, 2021   52,851,966   $52,853   $       $28,245,452   $(29,977,989)   (1,679,684)
                                    
Common stock issued for cash   500,000    500            9,500        10,000 
Common stock issued for services                            
Common stock issued for officer compensation                            
Common stock issued for Conversion on Note                            
Net Profit/(Loss)                       (115,048)   (115,048)
                                    
Balance December 31, 2021   53,351,966   $53,353   $       $28,254,952   $(30,093,037)   (1,784,732)
                                    
Common stock issued for cash   500,000    500            9,500        10,000 
Common stock issued for services                            
Common stock issued for officer compensation                            
Common stock issued for Conversion on Note                            
Net Profit/(Loss)                       (30,681    (30,681)
                                    
Balance March 31, 2022   53,851,966   $53,853   $       $28,264,452   $(30,123,718)   (1,805,413)
                                    
Common stock issued for cash                            
Common stock issued for services                            
Common stock issued for officer compensation                            
Common stock issued for Conversion on Note                            
Net Profit/(Loss)                       (154,682)   (154,682)
                                    
Balance June 30, 2022   53,851,966   $53,853   $       $28,264,452   $(30,278,400    (1,960,095)
                                    
Common stock issued for cash                            
Common stock issued for services   1,700,000    1,700                    1,700 
Common stock issued for officer compensation   3,500,000    3,500                    3,500 
Common stock issued for Conversion on Note                            
Preferred stock B issued for officer compensation           1,000,000    1,000             
                                    
Net Profit/(Loss)                       (73,678)   (73,678)
                                    
Balance September 30, 2022   59,051,966    59,053    1,000,000    1,000    28,264,452    (30,352078)   (2,027573)
                                    
Common stock issued for cash   62,600,000    62,600            253,900        316,500 
Common stock issued for debt settlement   136,312,440    136,312            587,812        724,124 
Common stock issued for officer compensation                            
Peaks Curative retained earnings                       (12,084)   (12,083)
Peaks common units                           30,217 
                                    
Net Profit/(Loss)                       98,464    98,464 
                                    
Balance December 31, 2022   257,964,406    257,965    1,000,000    1,000    29,106,164    (30,265,697)   (900,567)

 

F-3

 

 

Earth Science Tech, Inc. & Subsidiaries

Consolidated Statements of Cash Flows

 

  

For the Nine

Months Ended

December 31, 2022

  

For the Nine

Months Ended

December 31, 2021

 
Cash Flow From Operating Activities:          
Net Profit/(Loss)  $(129,896)  $3,203,941 
Changes in operating assets and liabilities:          
Increase/Decrease in prepaid expenses and other current assets       6,691 
Increase/Decrease in accrued settlement   (565,663)   18,761 
Stock issued for debt settlement   724,124     
Increase in inventory       6,644 
Decrease in other assets   (397,039)   (3,408,637)
Decrease in accounts payable   (300,780)   127,638 
Net Cash Used in Operating Activities   (669,254)   (44,962)
           
Investing Activities:          
Purchases of property and equipment       1,712 
Net Cash Used in Investing Activities       1,712 
           
Financing Activities:          
Proceeds from issuance of common stock   316,500    38,175 
Proceeds from Convertible Notes   350,000     
Intrinsic value of Conv Notes-Addtl Paid-in-Capital        
Net Cash Provided by Financing Activities   666,500    38,175 
           
Net Decrease in Cash   (2,754)   (5,075)
           
Cash - Beginning of period   26,942    16,161 
Cash - End of period  $24,188   $10,586 

 

F-4

 

 

EARTH SCIENCE TECH, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022

(UNAUDITED)

 

Note 1 — Organization and Nature of Operations

 

Earth Science Tech, Inc. (“ETST” or the “Company”) was incorporated under the laws of the State of Nevada on April 23, 2010, subsequently changed to the State of Florida on June 27, 2022. As of November 8, 2022, the Company is a holding entity set to acquire companies with its current focus in the health and wellness industry. The Company is presently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries RxCompoundStore.com, LLC. (“RxCompound”), Peaks Curative, LLC. (“Peaks”), and Earth Science Foundation, Inc. (“ESF”).

 

RxCompound is a compounding pharmacy that has historically focused on men’s health, specifically medical products directed at ED such as Tadalafil, and Sildenafil Citrate (the generic names for Cialis and Viagra, respectively) and longevity. Currently licensed to dispense in the state of Florida, New York, New Jersey, Delaware, Colorado, Rhode Island, and Arizona. RxCompound is in the application process to obtain licenses in the remaining states in which it is not yet licensed to dispense prescriptions. Furthermore, RxCompound recently obtained its hazardous room to compound hormonal creams within the month of December 2022 and is anticipated to have its sterile compounding room operational early 2023 to provide sterile products for injection.

 

Peaks is the telemedicine referral site facilitating asynchronous consultations for branded compound medications prepared at RxCompound. Peaks is currently positioned to prescribe to all 50 states utilizing Smart Doctors consultation services, but only able to fulfill prescriptions within RxCompound’s licensed states. Peaks will be able to fulfill more states as RxCompound obtains dispensing licenses in additional states. Patients who order Peaks via monthly subscription will be automatically enrolled into Peaks’ Loyalty Program. As a member of the loyalty program, members will receive credit to cover the costs on their Peaks facilitated online doctor consultations. The Peaks membership enrollment will occur automatically once becoming a monthly subscriber and automatically renewed at the time of the prescription renewal order. At the time of the renewal order, credits will be applied to cover the Peaks facilitated online doctor consultation.

 

Peaks’ strategy has been to launch the website within three phases to insure efficiency and proper performance. Peaks launched its first Phase, Phase I, in the month of June 2022, offering one product, Tadalafil in a gummy form within 3 different dosages and quantity offerings. After months of feedback, successful orders and refills, Peaks commenced its Phase II website upgrade. Phase II will enhance the patient experience as well as offering Tadalafil in the form of gummies and tablets (generic Cialis), and Sildenafil in the form of capsules and tablets (generic Viagra) all in three different dosages and quantity offerings. Once Phase II has been completed, Peaks plans to execute a marketing campaign within the RxCompound dispensing states to increase brand exposure and sales leading to Phase III. Phase III includes over the counter (“OTC”) (non-prescription) products such as supplements and topicals. The OTC products will be custom manufactured or fulfilled through partnered companies under Peaks brand and offered worldwide.

 

ESF is a favored entity of ETST, effectively being a non-profit organization that was incorporated on February 11, 2019, and is structured to accept grants and donations to help those in need of assistance in paying for prescription.

 

Note 2 — Summary of Significant Accounting Policies

 

Basis of presentation

 

The Company’s accounting policies used in the presentation of the accompanying consolidated financial statements conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied.

 

F-5

 

 

Principles of consolidation

 

The accompanying consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries Peaks and ESF. The Company’s acquisition of RxCompound was consummated on November 8, 2022, along with Peaks; however, RxCompound completed its PCAOB audit after the fiscal quarter that subsequently to period ended December 31, 2022, completed on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events).

 

All intercompany balances and transactions have been eliminated on consolidation.

 

Use of estimates and assumptions

 

The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change since there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

 

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.

 

Carrying value, recoverability, and impairment of long-lived assets

 

Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC’) 360 to evaluate its long-lived assets. The Company’s long-lived assets, which include property and equipment and a patent are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

 

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. Impairment of assets, if any, are included in operating expenses.

 

F-6

 

 

Cash and cash equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less to be cash and cash equivalents.

 

Related parties

 

The Company follows ASC 850 for the identification of related parties and disclosure of related party transactions.

 

Pursuant to this ASC related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Commitments and contingencies

 

The Company follows ASC 450 to account for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. This may result in contingent liabilities that are required to be accrued or disclosed in the financial statements. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Revenue recognition

 

The Company follows and implements ASC 606, Revenue from Contracts with Customers for revenue recognition. Although the new revenue standard is expected to have an immaterial effect, if any, on the Company’s ongoing net income, management did implement changes to the Company’s processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures.

 

F-7

 

 

The Company recognizes revenue from product sales or services rendered when control of the promised goods are transferred to the company’s clients in an amount that reflects the consideration to which management expects to be entitled in exchange for those goods and services. To achieve this core principle, management applies the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

 

Inventories

 

The Company did not hold any inventories during the period ended December 31, 2022. During the Period ended December 31, 2022, the Company’s operating entity Peaks fulfilled its sales directly through RxCompound, owned by the Company, but did not complete its PCAOB audit during the period ended December 31, 2022. RxCompound completed its PCAOB audit on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events). The Company will have its inventories stated at the lower of cost or market using the first in, first out (FIFO) method after the period ended December 31, 2022. A reserve will be established if necessary to reduce excess or obsolete inventories to their realizable value.

 

Cost of Sales

 

Components of costs of sales include product and shipping costs to customers and any inventory adjustments.

 

Shipping and Handling Costs

 

The Company accounts shipping and handling costs to customers as cost of revenue.

 

Research and development

 

Research and development costs are expensed as incurred. The Company’s research and development expenses relate to its engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general.

 

Income taxes

 

The Company follows ASC 740 in accounting for income taxes. Deferred tax assets and liabilities are determined based on the estimated future tax effects of net operating loss carry forwards and temporary differences between the tax bases of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records a valuation allowance for its deferred tax assets when management concludes that it is not more likely those assets will be recognized.

 

The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of December 31, 2021, the Company has not recorded any unrecognized tax benefits.

 

Interest and penalties related to liabilities for uncertain tax positions will be charged to interest and operating expenses, respectively. The Company has net operating loss carryforwards (NOL) for income tax purposes of approximately $6,150,613. This loss is allowed to be offset against future income until the year 2039 when the NOL’s will expire. The tax benefits relating to all timing differences have been fully reserved for in the valuation allowance account due to the substantial losses incurred through September 30, 2022. There was no change in the valuation allowance for the periods ended December 31, 2022, and 2021.

 

F-8

 

 

Internal Revenue Code Section 382 (“Section 382”) imposes limitations on the availability of a company’s net operating losses after certain ownership changes occur. The Section 382 limitation is based upon certain conclusions pertaining to the dates of ownership changes and the value of the Company on the dates of the ownership changes. It was determined that an ownership change occurred in October 2013 and March 2014. The amount of the Company’s net operating losses incurred prior to the ownership changes are limited based on the value of the Company on the date of the ownership change. Management has not determined the amount of net operating losses generated prior to the ownership change available to offset taxable income subsequent to the ownership change.

 

Net loss per common share

 

The Company follows ASC 260 to account for earnings per share. Basic earnings per common share calculations are determined by dividing net results from operations by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net results from operations by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

 

As of December 31, 2022, the Company has no warrants that are anti-dilutive and not included in the calculation of diluted loss per share.

 

Cash flows reporting

 

The Company follows ASC 230 to report cash flows. This standard classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by this standard to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports separately information about investing and financing activities not resulting in cash receipts or payments in the period pursuant this standard.

 

Stock based compensation

 

The Company follows ASC 718 in accounting for its stock-based compensation to employees. These standards state that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price of the Company’s common stock as of the date in which the obligation for payment of service is incurred.

 

Company accounts for transactions in which services are received from non-employees in exchange for equity instruments based on the fair value of the equity instrument exchanged in accordance with ASC 505-50.

 

Property and equipment

 

Property and equipment are recorded at cost net of accumulated depreciation. Depreciation is computed using the straight-line method based upon the estimated useful lives of the respective assets as follows:

 

Leasehold improvements   Shorter of useful life or term of lease
Signage   5 years
Furniture and equipment   5 years
Computer equipment  

5 years

 

F-9

 

 

The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from accounts and any resulting gains or losses are included in operations.

 

Recently issued accounting pronouncements

 

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Classification of Certain Cash Receipts and Cash Payments. The new standard will change the classification of certain cash payments and receipts within the cash flow statement. Specifically, payments for debt prepayment or debt extinguishment costs, including third-party costs, premiums paid, and other fees paid to lenders that are directly related to the debt prepayment or debt extinguishment, excluding accrued interest, will now be classified as financing activities. Previously, these payments were classified as operating expenses. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019, with early adoption permitted, and will be applied retrospectively. The Company does not expect that the adoption of this new standard will have a material impact on its consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases. This ASU requires lessees to recognize most leases on their balance sheets related to the rights and obligations created by those leases. The ASU also requires additional qualitative and quantitative disclosures related to the nature, timing and uncertainty of cash flows arising from leases. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its consolidated financial statements.

 

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation – Stock Compensation. The new standard modified several aspects of the accounting and reporting for employee share- based payments and related tax accounting impacts, including the presentation in the statements of operations and cash flows of certain tax benefits or deficiencies and employee tax withholdings, as well as the accounting for award forfeitures over the vesting period. The new standard was effective for the Company on April 1, 2017. The Company does not believe that the adoption of this new standard will have a material effect on its consolidated financial statements.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.

 

F-10

 

 

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles-Goodwill and Other, which simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. Instead, if “the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.” The guidance is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.

 

All other newly issued accounting pronouncements not yet effective have been deemed either immaterial or not applicable.

 

Intangible Assets

 

The Company’s balance of intangible assets on the condensed consolidated balance sheet net of accumulated amortizations $17,806 and $0 as of December 31, 2022, and December 31, 2021, from its Peaks telemedicine web platform.

 

Reclassification

 

Certain amounts from the prior period have been reclassified to conform to the current period presentation.

 

Note 3 — Going Concern

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. On December 31, 2022, the Company had negative working capital, an accumulated deficit of $30,265,697. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company as of November 8, 2022, became a holding entity set to acquire companies with its recent two acquisitions, RxCompound and Peaks both operating in the health and wellness industry. The Company’s cash position may not be sufficient to pay its obligations and support the Company’s daily operations. Management intends to raise additional funds by way of a public or private offering. Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues may provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate sufficient revenues by acquiring companies and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues.

 

The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Note 4 - Related Party Balances and Transactions

 

On November 8, 2022, the Company amended the Purchase Agreement for the Membership Units of the RxCompound and Peaks, dated November 3, 2021. Pursuant to the terms of the Amendment, the parties modified the Purchase Price on the November 3, 2021, agreement such that the Company agreed to issue a cumulative total of 53,700,000 shares of its restricted Common Stock in exchange for all outstanding Membership Units of both RxCompound and Peaks, (see Note 4, Related Party Balance and Transactions).

 

On December 29, 2022, Peaks completed its PCAOB audit and RxCompound completed its audit after the period ended December 31, 2022, on February 3, 2023, (see note 8 Subsequent Event).

 

F-11

 

 

Note 5 – Stockholders’ Equity

 

During the three months ended December 31, 2022, and 2021, the Company issued 62,600,000 and 0 restricted common shares for cash of $316,500 and $0 respectively, (see ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS).

 

During the three months ended December 31, 2022, and 2021, the Company issued 136,312,440 and 0 restricted common shares for debt settlements at a fair value of $724,124 and $0 respectively, (see RESULTS OF OPERATIONS and ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS).

 

Note 6 — Commitments and Contingencies

 

Legal Proceedings

 

The Company did not have any material legal proceedings during the period ended December 31, 2022.

 

Lease Agreements

 

The Company is presently located at RxCompound’s location at 8950 SW 74th Court Suite 101, Miami, FL, 33156 after the Purchase Agreement was consummated on November 8, 2022, (see Note 4, Related Party Balance and Transactions). RxCompound’s location sits in 1,900 sq ft composed of offices, cooking room, hazardous room, sterile compounding room, lobby, and storage. The lease requires monthly payments of $7,057 for a term of 36-months plus the single lump sum payment of $40,000 upon execution in June 2022.

 

Note 7 — Balance Sheet and Income Statement Footnotes

 

Accounts receivable represent normal trade obligations from customers that are subject to normal trade collection terms, without discounts or rebates. If collection is expected in one year or less, they are classified as current assets. If not, they are presented as non-current assets. Notwithstanding these collections, the Company periodically evaluates the collectability of accounts receivable and considers the need to establish an allowance for doubtful debts based upon historical collection experience and specifically identifiable information about its customers.

 

Accounts payable are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities

 

Accrued expenses of $86,183 as of December 31, 2022, mainly represent $67,410 in accrued payroll for the company’s CEO and CFO, and the remainder for accrued interest on Notes Payable.

 

General and administrative expenses were $5,599 and $61,526 for December 31, 2022, and 2021 respectively. For the three months ended December 31, 2022, $2,236 was employee compensation, $1,032 internet and computer expenses, and the remainder was on miscellaneous expenses.

 

Professional fees were $22,233 for the three months ended December 31, 2022. For the three months ended December 31, 2022, there were $9,500 in auditor fees, $6,200 in consulting fees, $5,000 in SEC legal fees and the remainder were miscellaneous fees.

 

Other income was $146,739 for the three months ended December 31, 2022, from a debt settlement, (see November 8, 2022, 8-K filing).

 

Interest expense was $(18,321) and $(2,452) for three months ended December 31, 2022, and 2021. Interest expense for three months ended December 31, 2022, was mainly due to Convertible Notes II and I (“VCAMJI Irrevocable Trust Convertible Note I” and VCAMJI Irrevocable Trust Note II”) and Revolving Promissory Note (“Issa El-Chelkh Revolving Promissory Note”), (see Item 2, Liquidity and Capital Resources).

 

Note 8 — Subsequent Events

 

On February 3, 2023, the Company received RxCompound’s audited financials pursuant to the previously announced Purchase and Sale Agreement dated November 8, 2022, and for the purposes set forth therein, the seller of RxCompound entered into a Purchase and Sale Agreement, pursuant to which the Company agreed to acquire the Seller.

 

The Company received an email on February 9, 2023 from the Autorité des Marchés Financiers (“the AMF”) with a complaint, in French dated January 23, 2023. The Complaint alleges that the Company's former CEO, Dr. Michele Aube, improperly raised capital for the Company and is claiming Forty Thousand Dollars in damages. Dr. Aube resigned in 2019. The Company has retained legal counsel in Quebec and will vigorously defend this claim.

 

F-12

 

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following section, Management’s Discussion and Analysis, should be read in conjunction with Earth Science Tech Inc.’s financial statements and the related notes thereto and contains forward-looking statements that involve risks and uncertainties, such as statements of the Company’s plans, objectives, expectations, and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this Report on Form 10-Q. The Company’s actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of many factors. The Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Report filed on Form 10-Q.

 

The following discussion should be read in conjunction with the company’s unaudited consolidated financial statements and related notes and other financial data included elsewhere in this report. See also the notes to the Company’s consolidated financial statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Company’s Registration Statement filed on Form 10-12g and the Company’s Annual Report filed on Form 10-K for the fiscal year ended March 31, 2022, as well as the Company’s Quarterly report filed on Form 10-Q for the period ending September 30, 2022.

 

OVERVIEW

 

The Company is a holding entity set to acquire companies with its current focus in the health and wellness industry. The Company is presently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries RxCompoundStore.com, LLC. (“RxCompound”), Peaks Curative, LLC. (“Peaks”), and Earth Science Foundation, Inc. (“ESF”).

 

RxCompound is a compounding pharmacy that has historically focused on men’s health, specifically medical products directed at ED such as Tadalafil, and Sildenafil Citrate (the generic names for Cialis and Viagra, respectively) and longevity. Currently licensed to dispense in the state of Florida, New York, New Jersey, Delaware, Colorado, Rhode Island, and Arizona. RxCompound is in the application process to obtain licenses in the remaining states in which it is not yet licensed to dispense prescriptions. Furthermore, RxCompound recently obtained its hazardous room to compound hormonal creams within the month of December 2022 and is anticipated to have its sterile compounding room operational early 2023 to provide sterile products for injection.

 

Peaks is the telemedicine referral site facilitating asynchronous consultations for branded compound medications prepared at RxCompound. Peaks is currently positioned to prescribe to all 50 states utilizing Smart Doctors consultation services, but only able to fulfill prescriptions within RxCompound’s licensed states. Peaks will be able to fulfill more states as RxCompound obtains dispensing licenses in additional states. Patients who order Peaks via monthly subscription will be automatically enrolled into Peaks’ Loyalty Program. As a member of the loyalty program, members will receive credit to cover the costs on their Peaks facilitated online doctor consultations. The Peaks membership enrollment will occur automatically once becoming a monthly subscriber and automatically renewed at the time of the prescription renewal order. At the time of the renewal order, credits will be applied to cover the Peaks facilitated online doctor consultation.

 

Peaks’ strategy has been to launch the website within three phases to insure efficiency and proper performance. Peaks launched its first Phase, Phase I, in the month of June 2022, offering one product, Tadalafil in a gummy form within 3 different dosages and quantity offerings. After months of feedback, successful orders and refills, Peaks commenced its Phase II website upgrade. Phase II will enhance the patient experience as well as offering Tadalafil in the form of gummies and tablets (generic Cialis), and Sildenafil in the form of capsules and tablets (generic Viagra) all in three different dosages and quantity offerings. Once Phase II has been completed, Peaks plans to execute a marketing campaign within the RxCompound dispensing states to increase brand exposure and sales leading to Phase III. Phase III includes over the counter (“OTC”) (non-prescription) products such as supplements and topicals. The OTC products will be custom manufactured or fulfilled through partnered companies under Peaks brand and offered worldwide.

 

ESF is a favored entity of ETST, effectively being a non-profit organization that was incorporated on February 11, 2019, and is structured to accept grants and donations to help those in need of assistance in paying for prescription.

 

3

 

 

Critical Accounting Policies and Estimates

 

The discussion and analysis of the Company’s financial condition and results of operations are based upon the Company’s condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses. In consultation with the Company’s Board of Directors, management has identified the following accounting policies that it believes are key to an understanding of its financial statements. These are important accounting policies that require management’s most difficult, subjective judgments.

 

Basis of Presentation

 

The Company’s accounting policies used in the presentation of the accompanying consolidated financial statements conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include all of the accounts of the Company and its wholly owned subsidiaries. The subsidiaries include Peaks and ESF (all intercompany balances and transactions have been eliminated on consolidation).

 

Use of Estimates and Assumptions

 

The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change since there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

 

4

 

 

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.

 

Carrying Value, Recoverability, and Impairment of Long-Lived Assets

 

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC’) 360 to evaluate its long-lived assets. The Company’s long-lived assets, which include property and equipment and a patent are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

 

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. Impairment of changes, if any, are included in operating expenses.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less to be cash and cash equivalents.

 

Related Parties

 

The Company follows ASC 850 for the identification of related parties and disclosure of related party transactions.

 

Pursuant to this ASC related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

5

 

 

Commitments and Contingencies

 

The Company follows ASC 450 to account for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. This may result in contingent liabilities that are required to be accrued or disclosed in the financial statements. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Revenue Recognition

 

The Company follows and implements ASC 606, Revenue from Contracts with Customers for revenue recognition. Although the new revenue standard is expected to have an immaterial effect, if any, on the Company’s ongoing net income, the Company did implement changes to the Company’s processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures.

 

The Company recognizes revenue from product sales or services rendered when control of the promised goods are transferred to the Company’s clients in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods and services. To achieve this core principle, the Company will apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

 

The Company recognizes its retail store revenue at point of sale, net of sales tax.

 

Inventories

 

The Company did not hold any inventories during the period ended December 31, 2022. During the Period ended December 31, 2022, the Company’s operating entity Peaks fulfills its sales directly through RxCompound, owned by the Company, but did not complete its PCAOB audit dur9ng the period ended December 31, 2022. RxCompound completed its PCAOB audit subsequently to the period ended December 31, 2022, on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events). The Company will have its inventories stated at the lower of cost or market using the first in, first out (FIFO) method subsequently to the period ended December 31, 2022. A reserve will be established if necessary to reduce excess or obsolete inventories to their realizable value.

 

Cost of Sales

 

Components of costs of sales include product and shipping costs to customers and any inventory adjustments.

 

6

 

 

Shipping and Handling Costs

 

The Company accounts shipping and handling costs to customers as cost of revenue.

 

Research and Development

 

Research and development costs are expensed as incurred. The Company’s research and development expenses relate to its engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general.

 

Net Loss Per Common Share

 

The Company follows ASC 260 to account for earnings per share. Basic earnings per common share calculations are determined by dividing net results from operations by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net results from operations by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

 

As of December 31, 2022, the Company has no warrants that are anti-dilutive and not included in the calculation of diluted loss per share.

 

Cash Flows Reporting

 

The Company follows ASC 230 to report cash flows. This standard classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by this standard to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports separately information about investing and financing activities not resulting in cash receipts or payments in the period pursuant this standard.

 

Stock Based Compensation

 

The Company follows ASC 718 in accounting for its stock-based compensation to employees. These standards state that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price of the Company’s common stock as of the date in which the obligation for payment of service is incurred.

 

Company accounts for transactions in which services are received from non-employees in exchange for equity instruments based on the fair value of the equity instrument exchanged in accordance with ASC 505-50.

 

Property and Equipment

 

Property and equipment are recorded at cost net of accumulated depreciation. Depreciation is computed using the straight-line method based upon the estimated useful lives of the respective assets as follows:

 

Leasehold improvements   Shorter of useful life or term of lease
Signage   5 years
Furniture and equipment   5 years
Computer equipment   5 years

 

The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from accounts and any resulting gains or losses are included in operations.

 

Liquidity and Capital Resources.

 

For the Nine-Month Period Ended December 31, 2022, versus December 31, 2021

 

During the nine months ended December 31, 2022, net cash used in the Company’s operating activities totaled $(817,360) compared to $(158,683) during the three months ended December 31, 2021. During the nine months ended

 

December 31, 2022, net cash used in investing activities totaled $0 compared to $1,712 provided by investing activities during the nine months ended December 31, 2021. During the nine months ended December 31, 2022, net cash provided by financing activities totaled $350,000 compared to $0 from financing activities during the nine months ended December 31, 2022.

 

Revolving Promissory Note Issa El-Chelkh issued 1/28/22 for cash received $50,000 will accrue at a rate of 5% on a 360-day year. Maturity date January 23, 2023. The Revolving Promissory Note from Issa El-Chelkh’s $250,000 revolving credit agreement issued on August 31, 2021.

 

Revolving Promissory Note Issa El-Chelkh issued 4/1/22 for cash received $200,000 will accrue at a rate of 5% on a 360-day year. Maturity date March 27, 2023. The Revolving Promissory Note from Issa El-Chelkh’s $250,000 revolving credit agreement issued on August 31, 2021, now holds $0 in remaining credit.

 

7

 

 

Convertible Note VCAMJI IRREV. TRUST issued 6/10/22 for cash received $150,000 will accrue at a rate of 10% on a 360-day year. Maturity date is June 5, 2023.

 

Convertible Note Robert Stevens issued 6/3/22 in the principal of $220,000, together with any interest. Maturity date is April 24, 2023.

 

Convertible Note VCAMJI IRREV. TRUST issued 7/02/22 for cash received $200,000 will accrue at a rate of 10% on a 360-day year. Maturity date is June 27, 2023.

 

On December 31, 2022, the Company had total liabilities of $2,383,335 with $829,348 in a month-to-month payment plan, (see filed period ended September 30, 2022, 10-Q Note 6, Legal Proceedings). In addition, the current liabilities also include $677,500 from friendly creditors, all being large shareholders, $220,000 in a settlement convertible note, $102,956 from a SBA EIDL loan and $110,363 due to RxCompound currently in a pending acquisition transaction, (See Note 4, Related Party Balances and Transaction and Note 5, Stockholder Equity).

 

On December 31, 2022, the Company had a stockholder’s equity totaling $(870,350) compared to an equity of $(1,805,413) for the period ending December 31, 2021.

 

RESULTS OF OPERATIONS

 

For the Nine Months Ended December 31, 2022, versus December 31, 2021

 

The Company’s revenue for the nine months ended December 31, 2022, was $2,533 compared to December 31, 2021, revenue totaling $13,942. The decrease in revenue is primarily attributed to the Company consummation Peaks on November 8, 2022, (see Note 4, Related Party Balance) and provided audited financials on December 30, 2022, (see Note 8, Subsequent Events) recently launching their platform with no marketing during its first phase, (see note 8, Overview).

 

8

 

 

The Company’s current liabilities for the nine months ended December 31, 2022, was $1,407,726 compared to December 31, 2021, current liabilities totaling $1,882,355. The decrease in current liabilities is primarily attributed to the Company settlement on October 25, 2022, with Giorgio R Saumat for his acquired debt totaling $625,624 in exchange for 62,562,440 shares of its restricted Common Stock and 1,000,000 shares of its Series B Preferred Stock, Dr. Issa El-Cheikh’s promissory note dated within 2014 totaling $155,791 in exchange for 16,300,000 shares of its restricted Common Stock, and a Loan Advance convertible note dated within February 2021, and Mario Portela for his convertible note dated within February 2022 $27,500, Note Payable I and Note Payable I Interest, in exchange for 2,750,000 shares of its restricted Common Stock, (see October 28, 2022’s 8-K filing).

 

The Company incurred operating expenses for the nine months ended December 31, 2022, totaling $918,068, compared to $165,081 during the nine months ended December 30, 2021. The increase in operating expenses can be attributed to the Company’s litigation expenses, settlements, and general and administrative expenses, (see filed period ended September 30, 2022, 10-Q Note 6, Legal Proceedings).

 

Officer compensation for the nine months ended December 31, 2022, was $4,500 in cash and $0 in stock-based compensation compared to $86,173 in cash and $46,058 in stock-based compensation during the nine months ended December 31, 2021. This increase is due its CEO, CFO, and the addition of its new president. On October 25, 2022, both the Company’s CEO and President agreed to defer receiving salary compensation until the Company is cash flow positive for 3 consecutive bi-week payroll periods, (see October 28, 2022’s 8-K filing)

 

The Company incurred general and administrative expenses of $161,540, during the nine months ended December 31, 2022, compared to $99,035 during the nine months ended December 31, 2021. This increase is due to the accrued receivership fees and cost, (see filed period ended September 30, 2022, 10-Q Note 6, Legal Proceedings).

 

The Company paid professional fees of $31,433, during the nine months ended December 31, 2022, compared to $6,065 during the nine months ended December 31, 2021. This increase is due to SEC legal and auditor fees.

 

The Company incurred costs of legal proceedings of $18,497 during the nine months ended December 31, 2022, compared to $7,267 during the nine months ended December 31, 2021.

 

The Company generated a net loss from continuing operations for the nine months ended December 31, 2022, and 2021 of approximately $(129,896) and $3,203,941, respectively. As of December 31, 2022, and March 31, 2022, the Company had current assets of $537,376 and $76,942, respectively, which included the following as of December 31, 2022: cash and cash equivalents of approximately $24,188; amounts due from RxCompound of $397,382; prepaid acquisition costs of $98,000; and telemedicine platform valued at $17,806; compared to the following as of March 31, 2022, cash and cash equivalents of approximately $26,942; amounts due from RxCompoundStore.com of $25,000; and prepaid acquisition costs of $25,000.

 

The Company’s Plan of Operation for the Next Twelve Months

 

The Company’s auditors have expressed doubt as to the Company’s ability to continue as a going concern in part, because on December 31, 2022, the Company had negative working capital, an accumulated deficit of $30,265,697.

 

The Company’s current liabilities have historically exceeded the Company’s Current Assets; and as of December 31, 2022, that trend was continued with the Company’s current liabilities of totaling $1,407,726 exceeding the Company’s current assets of $537,376 by $870,350. While this trend is certainly has not been part of the Company’s objectives, management does not see it as particularly significant because in considering the Company’s current liabilities, $600,000 of them are represented in a related party note held by “friendly” creditors, two who are also large shareholders, VCAMJI IRREV. TRUST in the amount of $350,000 in a convertible note and Dr. Issa El-Chelkh in the amount of $250,000 in a revolving promissory note. The remaining creditors are from the recent litigation settlements, $378,846 are composed of Fox Rothchild in the amount of $158,846 in a month-to-month payment plan and Robert L. Stevens in the amount of $220,000 in a convertible note, (see filed period ended September 30, 2022, 10-Q Note 6, Legal Proceedings).

 

9

 

 

Regardless of the forgoing issues, the Company will require additional debt or equity financing for its operations as currently conducted. The Company on November 8, 2022, consummated its two merger candidates that will generate revenues in the compounding pharmaceutical and telemedicine industries, (see Note 4, Related Party Balance and Transactions and Overview).

 

Historically the Company has had a strong base of existing shareholders who are committed to its vision. They have historically demonstrated a willingness to purchase shares of stock when they are offered and friendly convertible notes. If these shareholders were to cease purchasing shares and notes when offered, if the Company were unable to secure other sources of debt or equity financing, or if the Company were unable to secure sufficient financing and on terms that are acceptable to it, the Company would not be able to continue operations as currently planned. Additional funding primarily allows the Company to expedite the Company’s business plan. During the periods ending December 31, 2022, and December 31, 2021, the Company has met its capital requirements through a combination of operating activities and through external financing through the sale of its restricted common stock and convertible notes. The Company intends to continue through friendly convertible notes and the sale of its restricted common stock.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports filed under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company’s reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Although the Company’s management has not formally carried out an evaluation under the supervision and with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (“Exchange Act”), because of the relatively thin management structure that the Company currently maintains, the Company believes that the Company’s Principal Executive Officer and Principal Financial Officer have sufficient timely information to allow them to make necessary disclosures in a timely manner.

 

Based on this informal evaluation, the Company’s principal executive and principal financial and accounting officer concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) were effective as of December 31, 2022.

 

Management’s Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

 

10

 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Control and Financial Reporting

 

There were no other changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company did not have any material legal proceedings during the period ended December 31, 2022.

 

ITEM 1A. RISK FACTORS

 

The Company is a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and is not required to provide the information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the three months ended December 31, 2022, the Company issued 197,312,440 shares of its common stock for $1,032,724, in transactions that were exempt from registration under the Securities Act of 1933, as amended pursuant to Section 4(2) and/or Rule 506 promulgate under Regulation D. No gain or loss was recognized on the issuances. On October 8, 2022, the Company issued 2,000,000 shares and 2,000,000 shares to two creditors at $0.001 per share to settle claims. On October 10, 2022, the Company issued 16,300,000 shares, 4,000,000 shares, and 200,000 shares to three creditors at $0.001 per share to settle claims. On October 18, 2022, the Company issued 500,000 shares to an investor at $0.012 per share for cash. On October 18, 2022, the Company issued 1,000,000 shares, 2,000,000 shares, and 400,000 shares to three investors at $0.005 per share for cash. On October 20, 2022, the Company issued 400,000 shares, 500,000 shares, and 2,000,000 shares to three investors at $0.005 per share for cash. On October 21, 2022, the Company issued 2,000,000 shares, 1,000,000 shares, and 400,000 shares to three investors at $0.005 per share for cash. On October 24, 2022, the Company issued 62,562,440 shares to a creditor at $0.01 per share to settle claims. On October 25, 2022, the Company issued 2,000,000 shares, 1,000,000 shares, 1,000,000 shares, 400,000 shares, and 13,000,000 shares to five investors at $0.005 per share for cash. On October 25, 2022, the Company issued 2,750,000 shares to a creditor at $0.01 per share to settle claims. On October 25, 2022, the Company issued 19,750,000 shares, 17,000,000 shares, and 9,750,000 shares to three creditors at $0.001 per share to settle claims. On November 2, 2022, the Company issued 600,000 shares to an investor at $0.005 per share for cash. On November 3, 2022, the Company issued 1,200,000 shares to an investor at $0.005 per share for cash. On November 4, 2022, the Company issued 10,000,000 shares to an investor at $0.005 per share for cash. On November 7, 2022, the Company issued 1,000,000 shares to an investor at $0.005 per share for cash. On November 8, 2022, the Company issued 4,000,000 shares, 2,000,000 shares, 2,000,000 shares, 2,000,000 shares, and 1,000,000 shares to five investors at $0.005 per share for cash. On November 9, 2022, the Company issued 600,000 shares to an investor at $0.005 per share for cash. On November 14, 2022, the Company issued 1,000,000 shares to an investor at $0.005 per share for cash. On November 14, 2022, the Company issued 1,000,000 shares, 200,000 shares, 200,000 shares, 3,000,000 shares, 3,000,000 shares, 1,000,000 shares, 100,000 shares, 200,000 shares, 200,000 shares, 300,000 shares, 200,000 shares, 200,000 shares, 200,000 shares, 200,000 shares, 200,000 shares, and 400,000 shares to sixteen investors at $0.005 per share for cash.

 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None

 

ITEM 5. OTHER INFORMATION

 

None

 

11

 

 

ITEM 6. EXHIBITS

 

31.1   Certifications of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
     
31.2   Certifications of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
     
32.1   Certifications of Chief Executive Officer pursuant to 18 U.S.C. SEC. 1350 (Section 906 of Sarbanes-Oxley Act of 2002) +
     
32.2   Certifications of Chief Financial Officer pursuant to 18 U.S.C. SEC. 1350 (Section 906 of Sarbanes-Oxley Act of 2002) +
     
101.INS   Inline XBRL Instance Document *
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document *
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document *
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document *
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document *
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document *
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

12

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  EARTH SCIENCE TECH, INC.
     
Dated: February 10, 2023 By: /s/ Nickolas S. Tabraue
    Nickolas S. Tabraue
  Its: CEO and Director
     
Dated: February 10, 2023 By: /s/ Wendell Hecker
    Wendell Hecker,
  Its: Chief Financial Officer

 

13

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14

 

I, Nickolas S. Tabraue, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Earth Science Tech, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the Company’s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report the Company’s conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on the Company’s most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  EARTH SCIENCE TECH, INC.
     
Dated: February 10, 2023 By: /s/ Nickolas S. Tabraue
    Nickolas S. Tabraue
  Its: CEO and Director

 

 
EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14

 

I, Wendell Hecker, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Earth Science Tech, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the Company’s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report the company’s conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on the Company’s most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  EARTH SCIENCE TECH, INC.
     
Dated: February 10, 2023 By: /s/ Wendell Hecker
    Wendell Hecker,
  Its: Chief Financial Officer

 

 
EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Earth Science Tech, Inc. (the “Company”) on Form 10-Q for the period ending December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Nickolas S. Tabraue, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

  EARTH SCIENCE TECH, INC.
     
Dated: February 10, 2023 By: /s/ Nickolas S. Tabraue
    Nickolas S. Tabraue
  Its: CEO and Director

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Earth Science Tech, Inc. (the “Company”) on Form 10-Q for the period ending December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wendell Hecker, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

  EARTH SCIENCE TECH, INC.
     
Dated: February 10, 2023 By: /s/ Wendell Hecker
    Wendell Hecker
  Its: Chief Financial Officer

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EX-101.SCH 6 etst-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Nature of Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Related Party Balances and Transactions link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Balance Sheet and Income Statement Footnotes link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Schedule of Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Related Party Balances and Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Balance Sheet and Income Statement Footnotes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 etst-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 etst-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 etst-20221231_lab.xml XBRL LABEL FILE Short-Term Debt, Type [Axis] Accrued Settlement [Two Member] Convertible Note [One Member] Convertible Note [Two Member] Convertible Note [Three Member] Accrued Settlement [One Member] Debt Instrument [Axis] Convertible Note G H S [Member] Promissory Note GHS [Member] Convertible Note Four [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Leasehold Improvements [Member] Signage [Member] Furniture and Fixtures [Member] Computer Equipment [Member] Related Party [Axis] Rx Compound And Peaks [Member] Award Type [Axis] Restricted Stock [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Purchase Agreement [Member] Title of Individual [Axis] Chief Executive Officer [Member] Chief Financial Officer [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] ASSETS Current Assets: Cash Accounts Receivable(net allowance of $0 and $101,404 respectively ) Prepaid expenses and other current assets Inventory Total current assets Other Assets: Due from RxCompound Prepaid Acquisition Costs Telemedicine Platform Total other assets Total Assets LIABILITIES AND STOCKHOLDERS EQUITY Current Liabilities: Accounts payable PPP Loan Accrued settlement Convertible Notes Loan Advance Revolving Promissory Note SBA EDIL Loan Accrued expenses Interest Payable Promissory Note SBA Payable Due to RxCompoundStore.com, LLC. Note Payable Note Payable Interest Notes Payable - related party Total current liabilities Commitments and contingencies Stockholders’ (Deficit) Equity: Common stock, par value $0.001 per share, 750,000,000 shares authorized; 257,964,406 and 53,851,966 shares issued and outstanding as of December 31, 2022 and March 31, 2022 respectively Preferred stock B par value $0.001 per share 1,000,000 authorized and outstanding as of December 31, 2022 Additional paid-in capital Accumulated deficit Total stockholders’ (Deficit)Equity Total Liabilities and Stockholders’ (Deficit) Equity Statement of Financial Position [Abstract] Accounts receivable, allowance for credit loss, current Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares outstanding Revenue Cost of revenues Gross Profit Operating Expenses: Compensation - officers Officer compensation stock General and administrative Professional fees Loss on disposal of assets Bad debt expense Marketing Litigation Expense Cost of legal proceedings Total operating expenses Loss from operations Other Income (Expenses) Other Income Interest expense Interest Expense Note Payable Interest Interest SBA Loan Total other income (expenses) Net Profit/(Loss) before income taxes Income taxes Net Profit/(Loss) Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Common stock issued for cash Common stock issued for cash, shares Common stock issued for services Common stock issued for services, shares Common stock issued for officer compensation Common stock issued for officer compensation, shares Common stock issued for Conversion on Note Common stock issued for Conversion on Note, shares Net Profit/(Loss) Preferred stock B issued for officer compensation Preferred stock B issued for officer compensation, shares Common stock issued for debt settlement Common stock issued for debt settlement, shares Peaks Curative retained earnings Peaks common units Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash Flow From Operating Activities: Changes in operating assets and liabilities: Increase/Decrease in prepaid expenses and other current assets Increase/Decrease in accrued settlement Stock issued for debt settlement Increase in inventory Decrease in other assets Decrease in accounts payable Net Cash Used in Operating Activities Investing Activities: Purchases of property and equipment Net Cash Used in Investing Activities Financing Activities: Proceeds from issuance of common stock Proceeds from Convertible Notes Intrinsic value of Conv Notes-Addtl Paid-in-Capital Net Cash Provided by Financing Activities Net Decrease in Cash Cash - Beginning of period Cash - End of period Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Nature of Operations Accounting Policies [Abstract] Summary of Significant Accounting Policies Going Concern Related Party Transactions [Abstract] Related Party Balances and Transactions Equity [Abstract] Stockholders’ Equity Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Balance Sheet And Income Statement Footnotes Balance Sheet and Income Statement Footnotes Subsequent Events [Abstract] Subsequent Events Basis of presentation Principles of consolidation Use of estimates and assumptions Carrying value, recoverability, and impairment of long-lived assets Cash and cash equivalents Related parties Commitments and contingencies Revenue recognition Inventories Cost of Sales Shipping and Handling Costs Research and development Income taxes Net loss per common share Cash flows reporting Stock based compensation Property and equipment Recently issued accounting pronouncements Intangible Assets Reclassification Schedule of Property Plant and Equipment Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful lives disclosures Estimated useful lives Likelihood income tax percentage Unrecognized tax benefits Net operating loss carryforwards Net operating loss carry forwards expiration date Valuation allowance Antidilutive securities Intangible assets Accumulated deficit Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Issued cumulative shares Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Issued shares Issued value Common stock debt settlements Common stock debt settlements Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Area of Land Lease requires payments Lump sum payment Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Accrued payroll taxes General and administrative expenses Employee compensation Miscellaneous expenses Auditor fees Consulting fees Legal fees Other income Prepaid acquisition costs. Promissory note. Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer. Loan advance. Net operating loss carry forwards expiration date. Cash flows reporting [Policy Text Block] Signage [Member] Accrued Settlement [Two Member] Convertible Promissory Note [One Member] Convertible Note [Two Member] Convertible Note [Three Member] Convertible Note Four [Member] Convertible Note [One Member] Accrued Settlement [One Member] Rx Compound And Peaks [Member] Cost of legal proceedings. Interest income expense bank loan. Convertible Note GHS [Member] Promissory Note [Member] Promissory Note GHS [Member] Note payable interest. Stock issued during period preferred stockvalue officer compensation Stock issued during period preferred stock shares officer compensation. Stock issued during period value for debt settlement. Stock issued during period shares for debt settlement. Peaks curative retained earnings. Interest payable Cromongen Biotechnology Corporation [Member] Breach of contract amount. Costs and fees amount. Conversion value. Description of confidential settlement. Majorca Group, Ltd [Member] Strongbow Advisors, Inc. [Member] Settlement Agreement [Member] Litigation settlement amount. Litigation settlement percentage. Litigation settlement initial payments. Contingency expected trial commencement. William A. Leonard Jr. [Member] Purchase agreement [Member] Lump sum payment. Balance sheet and income statement footnotes [Text Block] Miscellaneous expenses Auditor fees. Consulting fees. Intrinsic value of Conv Notes-Addtl Paid-in-Capital. Assets, Current Other Assets, Noncurrent Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Gain (Loss) on Disposition of Assets Operating Expenses Operating Income (Loss) Interest Expense, Debt Interest Expense, Other Note payable interest InterestIncomeExpenseBankLoan Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI Increase (Decrease) in Inventories Increase (Decrease) in Other Operating Assets Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Commitments and Contingencies, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] EX-101.PRE 10 etst-20221231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - shares
9 Months Ended
Dec. 31, 2022
Feb. 09, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2022  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --03-31  
Entity File Number 000-55000  
Entity Registrant Name EARTH SCIENCE TECH, INC.  
Entity Central Index Key 0001538495  
Entity Tax Identification Number 80-0931484  
Entity Incorporation, State or Country Code FL  
Entity Address, Address Line One 8950 SW 74th CT  
Entity Address, Address Line Two Suite 101  
Entity Address, City or Town Miami  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33156  
City Area Code (786)  
Local Phone Number 375-7281  
Title of 12(b) Security Common Stock $0.001 par value  
Trading Symbol ETST  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   256,695,496
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Mar. 31, 2022
Current Assets:    
Cash $ 24,188 $ 26,942
Accounts Receivable(net allowance of $0 and $101,404 respectively )
Prepaid expenses and other current assets
Inventory
Total current assets 24,188 26,942
Other Assets:    
Due from RxCompound 397,382 25,000
Prepaid Acquisition Costs 98,000 25,000
Telemedicine Platform 17,806  
Total other assets 513,188 50,000
Total Assets 537,376 76,942
Current Liabilities:    
Accounts payable 119,331 202,270
PPP Loan 31,750
Loan Advance 50,000
Revolving Promissory Note 250,000 50,000
SBA EDIL Loan 102,956 106,800
Accrued expenses 86,183 311,610
Promissory Note 30,000
SBA Payable 10,359  
Due to RxCompoundStore.com, LLC. 110,363 1,895
Note Payable 27,500
Note Payable Interest 344
Notes Payable - related party 59,558
Total current liabilities 1,408,038 1,882,355
Commitments and contingencies
Stockholders’ (Deficit) Equity:    
Common stock, par value $0.001 per share, 750,000,000 shares authorized; 257,964,406 and 53,851,966 shares issued and outstanding as of December 31, 2022 and March 31, 2022 respectively 257,966 53,853
Preferred stock B par value $0.001 per share 1,000,000 authorized and outstanding as of December 31, 2022 1,000
Additional paid-in capital 29,106,164 28,264,452
Accumulated deficit (30,265,697) (30,123,718)
Total stockholders’ (Deficit)Equity (900,567) (1,805,413)
Total Liabilities and Stockholders’ (Deficit) Equity 537,376 76,942
Convertible Note G H S [Member]    
Current Liabilities:    
Interest Payable 83,475
Promissory Note GHS [Member]    
Current Liabilities:    
Interest Payable 14,429
Accrued Settlement [Two Member]    
Current Liabilities:    
Accrued settlement 158,846
Convertible Note [One Member]    
Current Liabilities:    
Convertible Notes 220,000
Convertible Note [Two Member]    
Current Liabilities:    
Convertible Notes 150,000
Convertible Note [Three Member]    
Current Liabilities:    
Convertible Notes 200,000
Accrued Settlement [One Member]    
Current Liabilities:    
Accrued settlement 585,886
Convertible Note Four [Member]    
Current Liabilities:    
Convertible Notes $ 326,838
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2022
Mar. 31, 2022
Statement of Financial Position [Abstract]    
Accounts receivable, allowance for credit loss, current $ 0 $ 101,404
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 750,000,000 750,000,000
Common stock, shares issued 257,964,406 53,851,966
Common stock, shares outstanding 257,964,406 53,851,966
Preferred stock, par value $ 0.001  
Preferred stock, shares authorized 1,000,000  
Preferred stock, shares outstanding 1,000,000  
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Short-Term Debt [Line Items]        
Revenue $ 2,533 $ 3,997 $ 2,533 $ 13,942
Cost of revenues 825 2,467 825 7,544
Gross Profit 1,708 1,530 1,708 6,398
Operating Expenses:        
Compensation - officers 9,654 30,846 86,173 46,058
Officer compensation stock 4,500
General and administrative 5,599 61,526 161,540 99,035
Professional fees 22,233 5,165 31,433 6,065
Loss on disposal of assets 1,712
Bad debt expense 4,944 4,944
Marketing 4,200 4,200
Litigation Expense 512,725
Cost of legal proceedings 8,297 18,497 7,267
Total operating expenses 49,983 102,481 819,068 165,081
Loss from operations (48,275) (100,951) (817,360) (158,683)
Other Income (Expenses) 166,037 724,062 3,408,930
Other Income        
Interest expense (18,321) (2,452) (29,565) (8,040)
Note Payable Interest (1,104)
Interest SBA Loan (977) (995) (5,929) (1,995)
Total other income (expenses) 146,739 (14,097) 687,464 3,362,624
Net Profit/(Loss) before income taxes 98,464 (115,048) (129,896) 3,203,941
Income taxes
Net Profit/(Loss) 98,464 (115,048) (129,896) 3,203,941
Convertible Note G H S [Member]        
Other Income        
Interest Expense (9,289) (32,203)
Promissory Note GHS [Member]        
Other Income        
Interest Expense $ (1,361) $ (4,068)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Sep. 30, 2021 $ 52,853 $ 28,245,452 $ (29,977,989) $ (1,679,684)
Beginning balance, shares at Sep. 30, 2021 52,851,966      
Common stock issued for cash $ 500 9,500 10,000
Common stock issued for cash, shares 500,000        
Common stock issued for services
Common stock issued for services, shares        
Common stock issued for officer compensation
Common stock issued for officer compensation, shares        
Common stock issued for Conversion on Note
Common stock issued for Conversion on Note, shares        
Net Profit/(Loss) (115,048) (115,048)
Ending balance, value at Dec. 31, 2021 $ 53,353 28,254,952 (30,093,037) (1,784,732)
Ending balance, shares at Dec. 31, 2021 53,351,966      
Common stock issued for cash $ 500 9,500 10,000
Common stock issued for cash, shares 500,000        
Common stock issued for services
Common stock issued for officer compensation
Common stock issued for Conversion on Note
Net Profit/(Loss) (30,681) (30,681)
Ending balance, value at Mar. 31, 2022 $ 53,853 28,264,452 (30,123,718) (1,805,413)
Ending balance, shares at Mar. 31, 2022 53,851,966      
Common stock issued for cash
Common stock issued for services
Common stock issued for officer compensation
Common stock issued for Conversion on Note
Net Profit/(Loss) (154,682) (154,682)
Ending balance, value at Jun. 30, 2022 $ 53,853 28,264,452 (30,278,400) (1,960,095)
Ending balance, shares at Jun. 30, 2022 53,851,966      
Beginning balance, value at Mar. 31, 2022 $ 53,853 28,264,452 (30,123,718) (1,805,413)
Beginning balance, shares at Mar. 31, 2022 53,851,966      
Net Profit/(Loss)         (129,896)
Ending balance, value at Dec. 31, 2022 $ 257,965 $ 1,000 29,106,164 (30,265,697) (900,567)
Ending balance, shares at Dec. 31, 2022 257,964,406 1,000,000      
Beginning balance, value at Jun. 30, 2022 $ 53,853 28,264,452 (30,278,400) (1,960,095)
Beginning balance, shares at Jun. 30, 2022 53,851,966      
Common stock issued for cash
Common stock issued for services $ 1,700 1,700
Common stock issued for services, shares 1,700,000        
Common stock issued for officer compensation $ 3,500 3,500
Common stock issued for officer compensation, shares 3,500,000        
Common stock issued for Conversion on Note
Net Profit/(Loss) (73,678) (73,678)
Preferred stock B issued for officer compensation $ 1,000
Preferred stock B issued for officer compensation, shares   1,000,000      
Ending balance, value at Sep. 30, 2022 $ 59,053 $ 1,000 28,264,452 (30,352,078) (2,027,573)
Ending balance, shares at Sep. 30, 2022 59,051,966 1,000,000      
Common stock issued for cash $ 62,600 253,900 316,500
Common stock issued for cash, shares 62,600,000        
Common stock issued for officer compensation
Net Profit/(Loss) 98,464 98,464
Common stock issued for debt settlement $ 136,312 587,812 724,124
Common stock issued for debt settlement, shares 136,312,440        
Peaks Curative retained earnings (12,084) (12,083)
Peaks common units 30,217
Ending balance, value at Dec. 31, 2022 $ 257,965 $ 1,000 $ 29,106,164 $ (30,265,697) $ (900,567)
Ending balance, shares at Dec. 31, 2022 257,964,406 1,000,000      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flow From Operating Activities:    
Net Profit/(Loss) $ (129,896) $ 3,203,941
Changes in operating assets and liabilities:    
Increase/Decrease in prepaid expenses and other current assets 6,691
Increase/Decrease in accrued settlement (565,663) 18,761
Stock issued for debt settlement 724,124
Increase in inventory 6,644
Decrease in other assets (397,039) (3,408,637)
Decrease in accounts payable (300,780) 127,638
Net Cash Used in Operating Activities (669,254) (44,962)
Investing Activities:    
Purchases of property and equipment 1,712
Net Cash Used in Investing Activities 1,712
Financing Activities:    
Proceeds from issuance of common stock 316,500 38,175
Proceeds from Convertible Notes 350,000
Intrinsic value of Conv Notes-Addtl Paid-in-Capital
Net Cash Provided by Financing Activities 666,500 38,175
Net Decrease in Cash (2,754) (5,075)
Cash - Beginning of period 26,942 16,161
Cash - End of period $ 24,188 $ 10,586
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Organization and Nature of Operations
9 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Nature of Operations

Note 1 — Organization and Nature of Operations

 

Earth Science Tech, Inc. (“ETST” or the “Company”) was incorporated under the laws of the State of Nevada on April 23, 2010, subsequently changed to the State of Florida on June 27, 2022. As of November 8, 2022, the Company is a holding entity set to acquire companies with its current focus in the health and wellness industry. The Company is presently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries RxCompoundStore.com, LLC. (“RxCompound”), Peaks Curative, LLC. (“Peaks”), and Earth Science Foundation, Inc. (“ESF”).

 

RxCompound is a compounding pharmacy that has historically focused on men’s health, specifically medical products directed at ED such as Tadalafil, and Sildenafil Citrate (the generic names for Cialis and Viagra, respectively) and longevity. Currently licensed to dispense in the state of Florida, New York, New Jersey, Delaware, Colorado, Rhode Island, and Arizona. RxCompound is in the application process to obtain licenses in the remaining states in which it is not yet licensed to dispense prescriptions. Furthermore, RxCompound recently obtained its hazardous room to compound hormonal creams within the month of December 2022 and is anticipated to have its sterile compounding room operational early 2023 to provide sterile products for injection.

 

Peaks is the telemedicine referral site facilitating asynchronous consultations for branded compound medications prepared at RxCompound. Peaks is currently positioned to prescribe to all 50 states utilizing Smart Doctors consultation services, but only able to fulfill prescriptions within RxCompound’s licensed states. Peaks will be able to fulfill more states as RxCompound obtains dispensing licenses in additional states. Patients who order Peaks via monthly subscription will be automatically enrolled into Peaks’ Loyalty Program. As a member of the loyalty program, members will receive credit to cover the costs on their Peaks facilitated online doctor consultations. The Peaks membership enrollment will occur automatically once becoming a monthly subscriber and automatically renewed at the time of the prescription renewal order. At the time of the renewal order, credits will be applied to cover the Peaks facilitated online doctor consultation.

 

Peaks’ strategy has been to launch the website within three phases to insure efficiency and proper performance. Peaks launched its first Phase, Phase I, in the month of June 2022, offering one product, Tadalafil in a gummy form within 3 different dosages and quantity offerings. After months of feedback, successful orders and refills, Peaks commenced its Phase II website upgrade. Phase II will enhance the patient experience as well as offering Tadalafil in the form of gummies and tablets (generic Cialis), and Sildenafil in the form of capsules and tablets (generic Viagra) all in three different dosages and quantity offerings. Once Phase II has been completed, Peaks plans to execute a marketing campaign within the RxCompound dispensing states to increase brand exposure and sales leading to Phase III. Phase III includes over the counter (“OTC”) (non-prescription) products such as supplements and topicals. The OTC products will be custom manufactured or fulfilled through partnered companies under Peaks brand and offered worldwide.

 

ESF is a favored entity of ETST, effectively being a non-profit organization that was incorporated on February 11, 2019, and is structured to accept grants and donations to help those in need of assistance in paying for prescription.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies
9 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

 

Basis of presentation

 

The Company’s accounting policies used in the presentation of the accompanying consolidated financial statements conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied.

 

 

Principles of consolidation

 

The accompanying consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries Peaks and ESF. The Company’s acquisition of RxCompound was consummated on November 8, 2022, along with Peaks; however, RxCompound completed its PCAOB audit after the fiscal quarter that subsequently to period ended December 31, 2022, completed on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events).

 

All intercompany balances and transactions have been eliminated on consolidation.

 

Use of estimates and assumptions

 

The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change since there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

 

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.

 

Carrying value, recoverability, and impairment of long-lived assets

 

Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC’) 360 to evaluate its long-lived assets. The Company’s long-lived assets, which include property and equipment and a patent are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

 

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. Impairment of assets, if any, are included in operating expenses.

 

 

Cash and cash equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less to be cash and cash equivalents.

 

Related parties

 

The Company follows ASC 850 for the identification of related parties and disclosure of related party transactions.

 

Pursuant to this ASC related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Commitments and contingencies

 

The Company follows ASC 450 to account for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. This may result in contingent liabilities that are required to be accrued or disclosed in the financial statements. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Revenue recognition

 

The Company follows and implements ASC 606, Revenue from Contracts with Customers for revenue recognition. Although the new revenue standard is expected to have an immaterial effect, if any, on the Company’s ongoing net income, management did implement changes to the Company’s processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures.

 

 

The Company recognizes revenue from product sales or services rendered when control of the promised goods are transferred to the company’s clients in an amount that reflects the consideration to which management expects to be entitled in exchange for those goods and services. To achieve this core principle, management applies the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

 

Inventories

 

The Company did not hold any inventories during the period ended December 31, 2022. During the Period ended December 31, 2022, the Company’s operating entity Peaks fulfilled its sales directly through RxCompound, owned by the Company, but did not complete its PCAOB audit during the period ended December 31, 2022. RxCompound completed its PCAOB audit on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events). The Company will have its inventories stated at the lower of cost or market using the first in, first out (FIFO) method after the period ended December 31, 2022. A reserve will be established if necessary to reduce excess or obsolete inventories to their realizable value.

 

Cost of Sales

 

Components of costs of sales include product and shipping costs to customers and any inventory adjustments.

 

Shipping and Handling Costs

 

The Company accounts shipping and handling costs to customers as cost of revenue.

 

Research and development

 

Research and development costs are expensed as incurred. The Company’s research and development expenses relate to its engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general.

 

Income taxes

 

The Company follows ASC 740 in accounting for income taxes. Deferred tax assets and liabilities are determined based on the estimated future tax effects of net operating loss carry forwards and temporary differences between the tax bases of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records a valuation allowance for its deferred tax assets when management concludes that it is not more likely those assets will be recognized.

 

The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of December 31, 2021, the Company has not recorded any unrecognized tax benefits.

 

Interest and penalties related to liabilities for uncertain tax positions will be charged to interest and operating expenses, respectively. The Company has net operating loss carryforwards (NOL) for income tax purposes of approximately $6,150,613. This loss is allowed to be offset against future income until the year 2039 when the NOL’s will expire. The tax benefits relating to all timing differences have been fully reserved for in the valuation allowance account due to the substantial losses incurred through September 30, 2022. There was no change in the valuation allowance for the periods ended December 31, 2022, and 2021.

 

 

Internal Revenue Code Section 382 (“Section 382”) imposes limitations on the availability of a company’s net operating losses after certain ownership changes occur. The Section 382 limitation is based upon certain conclusions pertaining to the dates of ownership changes and the value of the Company on the dates of the ownership changes. It was determined that an ownership change occurred in October 2013 and March 2014. The amount of the Company’s net operating losses incurred prior to the ownership changes are limited based on the value of the Company on the date of the ownership change. Management has not determined the amount of net operating losses generated prior to the ownership change available to offset taxable income subsequent to the ownership change.

 

Net loss per common share

 

The Company follows ASC 260 to account for earnings per share. Basic earnings per common share calculations are determined by dividing net results from operations by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net results from operations by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

 

As of December 31, 2022, the Company has no warrants that are anti-dilutive and not included in the calculation of diluted loss per share.

 

Cash flows reporting

 

The Company follows ASC 230 to report cash flows. This standard classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by this standard to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports separately information about investing and financing activities not resulting in cash receipts or payments in the period pursuant this standard.

 

Stock based compensation

 

The Company follows ASC 718 in accounting for its stock-based compensation to employees. These standards state that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price of the Company’s common stock as of the date in which the obligation for payment of service is incurred.

 

Company accounts for transactions in which services are received from non-employees in exchange for equity instruments based on the fair value of the equity instrument exchanged in accordance with ASC 505-50.

 

Property and equipment

 

Property and equipment are recorded at cost net of accumulated depreciation. Depreciation is computed using the straight-line method based upon the estimated useful lives of the respective assets as follows:

 

Leasehold improvements   Shorter of useful life or term of lease
Signage   5 years
Furniture and equipment   5 years
Computer equipment  

5 years

 

 

The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from accounts and any resulting gains or losses are included in operations.

 

Recently issued accounting pronouncements

 

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Classification of Certain Cash Receipts and Cash Payments. The new standard will change the classification of certain cash payments and receipts within the cash flow statement. Specifically, payments for debt prepayment or debt extinguishment costs, including third-party costs, premiums paid, and other fees paid to lenders that are directly related to the debt prepayment or debt extinguishment, excluding accrued interest, will now be classified as financing activities. Previously, these payments were classified as operating expenses. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019, with early adoption permitted, and will be applied retrospectively. The Company does not expect that the adoption of this new standard will have a material impact on its consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases. This ASU requires lessees to recognize most leases on their balance sheets related to the rights and obligations created by those leases. The ASU also requires additional qualitative and quantitative disclosures related to the nature, timing and uncertainty of cash flows arising from leases. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its consolidated financial statements.

 

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation – Stock Compensation. The new standard modified several aspects of the accounting and reporting for employee share- based payments and related tax accounting impacts, including the presentation in the statements of operations and cash flows of certain tax benefits or deficiencies and employee tax withholdings, as well as the accounting for award forfeitures over the vesting period. The new standard was effective for the Company on April 1, 2017. The Company does not believe that the adoption of this new standard will have a material effect on its consolidated financial statements.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.

 

 

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles-Goodwill and Other, which simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. Instead, if “the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.” The guidance is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.

 

All other newly issued accounting pronouncements not yet effective have been deemed either immaterial or not applicable.

 

Intangible Assets

 

The Company’s balance of intangible assets on the condensed consolidated balance sheet net of accumulated amortizations $17,806 and $0 as of December 31, 2022, and December 31, 2021, from its Peaks telemedicine web platform.

 

Reclassification

 

Certain amounts from the prior period have been reclassified to conform to the current period presentation.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Going Concern
9 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

Note 3 — Going Concern

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. On December 31, 2022, the Company had negative working capital, an accumulated deficit of $30,265,697. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company as of November 8, 2022, became a holding entity set to acquire companies with its recent two acquisitions, RxCompound and Peaks both operating in the health and wellness industry. The Company’s cash position may not be sufficient to pay its obligations and support the Company’s daily operations. Management intends to raise additional funds by way of a public or private offering. Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues may provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate sufficient revenues by acquiring companies and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues.

 

The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Balances and Transactions
9 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Party Balances and Transactions

Note 4 - Related Party Balances and Transactions

 

On November 8, 2022, the Company amended the Purchase Agreement for the Membership Units of the RxCompound and Peaks, dated November 3, 2021. Pursuant to the terms of the Amendment, the parties modified the Purchase Price on the November 3, 2021, agreement such that the Company agreed to issue a cumulative total of 53,700,000 shares of its restricted Common Stock in exchange for all outstanding Membership Units of both RxCompound and Peaks, (see Note 4, Related Party Balance and Transactions).

 

On December 29, 2022, Peaks completed its PCAOB audit and RxCompound completed its audit after the period ended December 31, 2022, on February 3, 2023, (see note 8 Subsequent Event).

 

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ Equity
9 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Stockholders’ Equity

Note 5 – Stockholders’ Equity

 

During the three months ended December 31, 2022, and 2021, the Company issued 62,600,000 and 0 restricted common shares for cash of $316,500 and $0 respectively, (see ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS).

 

During the three months ended December 31, 2022, and 2021, the Company issued 136,312,440 and 0 restricted common shares for debt settlements at a fair value of $724,124 and $0 respectively, (see RESULTS OF OPERATIONS and ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS).

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies
9 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 — Commitments and Contingencies

 

Legal Proceedings

 

The Company did not have any material legal proceedings during the period ended December 31, 2022.

 

Lease Agreements

 

The Company is presently located at RxCompound’s location at 8950 SW 74th Court Suite 101, Miami, FL, 33156 after the Purchase Agreement was consummated on November 8, 2022, (see Note 4, Related Party Balance and Transactions). RxCompound’s location sits in 1,900 sq ft composed of offices, cooking room, hazardous room, sterile compounding room, lobby, and storage. The lease requires monthly payments of $7,057 for a term of 36-months plus the single lump sum payment of $40,000 upon execution in June 2022.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheet and Income Statement Footnotes
9 Months Ended
Dec. 31, 2022
Balance Sheet And Income Statement Footnotes  
Balance Sheet and Income Statement Footnotes

Note 7 — Balance Sheet and Income Statement Footnotes

 

Accounts receivable represent normal trade obligations from customers that are subject to normal trade collection terms, without discounts or rebates. If collection is expected in one year or less, they are classified as current assets. If not, they are presented as non-current assets. Notwithstanding these collections, the Company periodically evaluates the collectability of accounts receivable and considers the need to establish an allowance for doubtful debts based upon historical collection experience and specifically identifiable information about its customers.

 

Accounts payable are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities

 

Accrued expenses of $86,183 as of December 31, 2022, mainly represent $67,410 in accrued payroll for the company’s CEO and CFO, and the remainder for accrued interest on Notes Payable.

 

General and administrative expenses were $5,599 and $61,526 for December 31, 2022, and 2021 respectively. For the three months ended December 31, 2022, $2,236 was employee compensation, $1,032 internet and computer expenses, and the remainder was on miscellaneous expenses.

 

Professional fees were $22,233 for the three months ended December 31, 2022. For the three months ended December 31, 2022, there were $9,500 in auditor fees, $6,200 in consulting fees, $5,000 in SEC legal fees and the remainder were miscellaneous fees.

 

Other income was $146,739 for the three months ended December 31, 2022, from a debt settlement, (see November 8, 2022, 8-K filing).

 

Interest expense was $(18,321) and $(2,452) for three months ended December 31, 2022, and 2021. Interest expense for three months ended December 31, 2022, was mainly due to Convertible Notes II and I (“VCAMJI Irrevocable Trust Convertible Note I” and VCAMJI Irrevocable Trust Note II”) and Revolving Promissory Note (“Issa El-Chelkh Revolving Promissory Note”), (see Item 2, Liquidity and Capital Resources).

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
9 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 8 — Subsequent Events

 

On February 3, 2023, the Company received RxCompound’s audited financials pursuant to the previously announced Purchase and Sale Agreement dated November 8, 2022, and for the purposes set forth therein, the seller of RxCompound entered into a Purchase and Sale Agreement, pursuant to which the Company agreed to acquire the Seller.

 

The Company received an email on February 9, 2023 from the Autorité des Marchés Financiers (“the AMF”) with a complaint, in French dated January 23, 2023. The Complaint alleges that the Company's former CEO, Dr. Michele Aube, improperly raised capital for the Company and is claiming Forty Thousand Dollars in damages. Dr. Aube resigned in 2019. The Company has retained legal counsel in Quebec and will vigorously defend this claim.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

The Company’s accounting policies used in the presentation of the accompanying consolidated financial statements conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied.

 

 

Principles of consolidation

Principles of consolidation

 

The accompanying consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries Peaks and ESF. The Company’s acquisition of RxCompound was consummated on November 8, 2022, along with Peaks; however, RxCompound completed its PCAOB audit after the fiscal quarter that subsequently to period ended December 31, 2022, completed on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events).

 

All intercompany balances and transactions have been eliminated on consolidation.

 

Use of estimates and assumptions

Use of estimates and assumptions

 

The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change since there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

 

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.

 

Carrying value, recoverability, and impairment of long-lived assets

Carrying value, recoverability, and impairment of long-lived assets

 

Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC’) 360 to evaluate its long-lived assets. The Company’s long-lived assets, which include property and equipment and a patent are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

 

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. Impairment of assets, if any, are included in operating expenses.

 

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less to be cash and cash equivalents.

 

Related parties

Related parties

 

The Company follows ASC 850 for the identification of related parties and disclosure of related party transactions.

 

Pursuant to this ASC related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Commitments and contingencies

Commitments and contingencies

 

The Company follows ASC 450 to account for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. This may result in contingent liabilities that are required to be accrued or disclosed in the financial statements. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

Revenue recognition

Revenue recognition

 

The Company follows and implements ASC 606, Revenue from Contracts with Customers for revenue recognition. Although the new revenue standard is expected to have an immaterial effect, if any, on the Company’s ongoing net income, management did implement changes to the Company’s processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures.

 

 

The Company recognizes revenue from product sales or services rendered when control of the promised goods are transferred to the company’s clients in an amount that reflects the consideration to which management expects to be entitled in exchange for those goods and services. To achieve this core principle, management applies the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.

 

Inventories

Inventories

 

The Company did not hold any inventories during the period ended December 31, 2022. During the Period ended December 31, 2022, the Company’s operating entity Peaks fulfilled its sales directly through RxCompound, owned by the Company, but did not complete its PCAOB audit during the period ended December 31, 2022. RxCompound completed its PCAOB audit on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events). The Company will have its inventories stated at the lower of cost or market using the first in, first out (FIFO) method after the period ended December 31, 2022. A reserve will be established if necessary to reduce excess or obsolete inventories to their realizable value.

 

Cost of Sales

Cost of Sales

 

Components of costs of sales include product and shipping costs to customers and any inventory adjustments.

 

Shipping and Handling Costs

Shipping and Handling Costs

 

The Company accounts shipping and handling costs to customers as cost of revenue.

 

Research and development

Research and development

 

Research and development costs are expensed as incurred. The Company’s research and development expenses relate to its engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general.

 

Income taxes

Income taxes

 

The Company follows ASC 740 in accounting for income taxes. Deferred tax assets and liabilities are determined based on the estimated future tax effects of net operating loss carry forwards and temporary differences between the tax bases of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records a valuation allowance for its deferred tax assets when management concludes that it is not more likely those assets will be recognized.

 

The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of December 31, 2021, the Company has not recorded any unrecognized tax benefits.

 

Interest and penalties related to liabilities for uncertain tax positions will be charged to interest and operating expenses, respectively. The Company has net operating loss carryforwards (NOL) for income tax purposes of approximately $6,150,613. This loss is allowed to be offset against future income until the year 2039 when the NOL’s will expire. The tax benefits relating to all timing differences have been fully reserved for in the valuation allowance account due to the substantial losses incurred through September 30, 2022. There was no change in the valuation allowance for the periods ended December 31, 2022, and 2021.

 

 

Internal Revenue Code Section 382 (“Section 382”) imposes limitations on the availability of a company’s net operating losses after certain ownership changes occur. The Section 382 limitation is based upon certain conclusions pertaining to the dates of ownership changes and the value of the Company on the dates of the ownership changes. It was determined that an ownership change occurred in October 2013 and March 2014. The amount of the Company’s net operating losses incurred prior to the ownership changes are limited based on the value of the Company on the date of the ownership change. Management has not determined the amount of net operating losses generated prior to the ownership change available to offset taxable income subsequent to the ownership change.

 

Net loss per common share

Net loss per common share

 

The Company follows ASC 260 to account for earnings per share. Basic earnings per common share calculations are determined by dividing net results from operations by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net results from operations by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

 

As of December 31, 2022, the Company has no warrants that are anti-dilutive and not included in the calculation of diluted loss per share.

 

Cash flows reporting

Cash flows reporting

 

The Company follows ASC 230 to report cash flows. This standard classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by this standard to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports separately information about investing and financing activities not resulting in cash receipts or payments in the period pursuant this standard.

 

Stock based compensation

Stock based compensation

 

The Company follows ASC 718 in accounting for its stock-based compensation to employees. These standards state that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price of the Company’s common stock as of the date in which the obligation for payment of service is incurred.

 

Company accounts for transactions in which services are received from non-employees in exchange for equity instruments based on the fair value of the equity instrument exchanged in accordance with ASC 505-50.

 

Property and equipment

Property and equipment

 

Property and equipment are recorded at cost net of accumulated depreciation. Depreciation is computed using the straight-line method based upon the estimated useful lives of the respective assets as follows:

 

Leasehold improvements   Shorter of useful life or term of lease
Signage   5 years
Furniture and equipment   5 years
Computer equipment  

5 years

 

 

The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from accounts and any resulting gains or losses are included in operations.

 

Recently issued accounting pronouncements

Recently issued accounting pronouncements

 

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Classification of Certain Cash Receipts and Cash Payments. The new standard will change the classification of certain cash payments and receipts within the cash flow statement. Specifically, payments for debt prepayment or debt extinguishment costs, including third-party costs, premiums paid, and other fees paid to lenders that are directly related to the debt prepayment or debt extinguishment, excluding accrued interest, will now be classified as financing activities. Previously, these payments were classified as operating expenses. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019, with early adoption permitted, and will be applied retrospectively. The Company does not expect that the adoption of this new standard will have a material impact on its consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases. This ASU requires lessees to recognize most leases on their balance sheets related to the rights and obligations created by those leases. The ASU also requires additional qualitative and quantitative disclosures related to the nature, timing and uncertainty of cash flows arising from leases. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its consolidated financial statements.

 

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation – Stock Compensation. The new standard modified several aspects of the accounting and reporting for employee share- based payments and related tax accounting impacts, including the presentation in the statements of operations and cash flows of certain tax benefits or deficiencies and employee tax withholdings, as well as the accounting for award forfeitures over the vesting period. The new standard was effective for the Company on April 1, 2017. The Company does not believe that the adoption of this new standard will have a material effect on its consolidated financial statements.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.

 

 

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles-Goodwill and Other, which simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. Instead, if “the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.” The guidance is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.

 

All other newly issued accounting pronouncements not yet effective have been deemed either immaterial or not applicable.

 

Intangible Assets

Intangible Assets

 

The Company’s balance of intangible assets on the condensed consolidated balance sheet net of accumulated amortizations $17,806 and $0 as of December 31, 2022, and December 31, 2021, from its Peaks telemedicine web platform.

 

Reclassification

Reclassification

 

Certain amounts from the prior period have been reclassified to conform to the current period presentation.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Property Plant and Equipment

 

Leasehold improvements   Shorter of useful life or term of lease
Signage   5 years
Furniture and equipment   5 years
Computer equipment  

5 years

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule of Property Plant and Equipment (Details)
9 Months Ended
Dec. 31, 2022
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives disclosures Shorter of useful life or term of lease
Signage [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 years
Furniture and Fixtures [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 years
Computer Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 years
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Likelihood income tax percentage greater than 50% likelihood  
Unrecognized tax benefits   $ 0
Net operating loss carryforwards $ 6,150,613  
Net operating loss carry forwards expiration date the year 2039 when the NOL’s will expire  
Valuation allowance $ 0 0
Antidilutive securities 0  
Intangible assets $ 17,806 $ 0
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Going Concern (Details Narrative) - USD ($)
Dec. 31, 2022
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 30,265,697 $ 30,123,718
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Balances and Transactions (Details Narrative) - shares
3 Months Ended
Nov. 03, 2021
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]      
Issued cumulative shares   62,600,000 0
Rx Compound And Peaks [Member]      
Related Party Transaction [Line Items]      
Issued cumulative shares 53,700,000    
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Issued shares 62,600,000 0
Issued value $ 316,500 $ 0
Common stock debt settlements $ 724,124  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Common stock debt settlements 136,312,440 0
Common stock debt settlements $ 724,124 $ 0
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies (Details Narrative) - Purchase Agreement [Member]
Nov. 08, 2022
USD ($)
ft²
Jun. 30, 2022
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Area of Land | ft² 1,900  
Lease requires payments $ 7,057  
Lump sum payment   $ 40,000
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheet and Income Statement Footnotes (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]          
Accrued expenses $ 86,183   $ 86,183   $ 311,610
General and administrative expenses 5,599 $ 61,526 161,540 $ 99,035  
Employee compensation 2,236        
Miscellaneous expenses 1,032        
Professional fees 22,233 5,165 31,433 6,065  
Auditor fees 9,500        
Consulting fees 6,200        
Legal fees 5,000        
Other income 146,739 (14,097) 687,464 3,362,624  
Interest expense (18,321) $ (2,452) (29,565) $ (8,040)  
Chief Executive Officer [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]          
Accrued expenses 86,183   86,183    
Chief Financial Officer [Member]          
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]          
Accrued payroll taxes $ 67,410   $ 67,410    
XML 34 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001538495 2022-04-01 2022-12-31 0001538495 2023-02-09 0001538495 2022-12-31 0001538495 2022-03-31 0001538495 ETST:AccruedSettlementTwoMember 2022-12-31 0001538495 ETST:AccruedSettlementTwoMember 2022-03-31 0001538495 ETST:ConvertibleNoteOneMember 2022-12-31 0001538495 ETST:ConvertibleNoteOneMember 2022-03-31 0001538495 ETST:ConvertibleNoteTwoMember 2022-12-31 0001538495 ETST:ConvertibleNoteTwoMember 2022-03-31 0001538495 ETST:ConvertibleNoteThreeMember 2022-12-31 0001538495 ETST:ConvertibleNoteThreeMember 2022-03-31 0001538495 ETST:AccruedSettlementOneMember 2022-12-31 0001538495 ETST:AccruedSettlementOneMember 2022-03-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-03-31 0001538495 ETST:PromissoryNoteGHSMember 2022-12-31 0001538495 ETST:PromissoryNoteGHSMember 2022-03-31 0001538495 ETST:ConvertibleNoteFourMember 2022-12-31 0001538495 ETST:ConvertibleNoteFourMember 2022-03-31 0001538495 2022-10-01 2022-12-31 0001538495 2021-10-01 2021-12-31 0001538495 2021-04-01 2021-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-10-01 2022-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2021-10-01 2021-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2022-04-01 2022-12-31 0001538495 ETST:ConvertibleNoteGHSMember 2021-04-01 2021-12-31 0001538495 ETST:PromissoryNoteGHSMember 2022-10-01 2022-12-31 0001538495 ETST:PromissoryNoteGHSMember 2021-10-01 2021-12-31 0001538495 ETST:PromissoryNoteGHSMember 2022-04-01 2022-12-31 0001538495 ETST:PromissoryNoteGHSMember 2021-04-01 2021-12-31 0001538495 us-gaap:CommonStockMember 2021-09-30 0001538495 us-gaap:PreferredStockMember 2021-09-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001538495 us-gaap:RetainedEarningsMember 2021-09-30 0001538495 2021-09-30 0001538495 us-gaap:CommonStockMember 2021-12-31 0001538495 us-gaap:PreferredStockMember 2021-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001538495 us-gaap:RetainedEarningsMember 2021-12-31 0001538495 2021-12-31 0001538495 us-gaap:CommonStockMember 2022-03-31 0001538495 us-gaap:PreferredStockMember 2022-03-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001538495 us-gaap:RetainedEarningsMember 2022-03-31 0001538495 us-gaap:CommonStockMember 2022-06-30 0001538495 us-gaap:PreferredStockMember 2022-06-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001538495 us-gaap:RetainedEarningsMember 2022-06-30 0001538495 2022-06-30 0001538495 us-gaap:CommonStockMember 2022-09-30 0001538495 us-gaap:PreferredStockMember 2022-09-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001538495 us-gaap:RetainedEarningsMember 2022-09-30 0001538495 2022-09-30 0001538495 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001538495 us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001538495 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001538495 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001538495 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001538495 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001538495 2022-01-01 2022-03-31 0001538495 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001538495 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001538495 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001538495 2022-04-01 2022-06-30 0001538495 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001538495 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001538495 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001538495 2022-07-01 2022-09-30 0001538495 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001538495 us-gaap:PreferredStockMember 2022-10-01 2022-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001538495 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001538495 us-gaap:CommonStockMember 2022-12-31 0001538495 us-gaap:PreferredStockMember 2022-12-31 0001538495 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001538495 us-gaap:RetainedEarningsMember 2022-12-31 0001538495 2021-03-31 0001538495 us-gaap:LeaseholdImprovementsMember 2022-04-01 2022-12-31 0001538495 ETST:SignageMember 2022-04-01 2022-12-31 0001538495 us-gaap:FurnitureAndFixturesMember 2022-04-01 2022-12-31 0001538495 us-gaap:ComputerEquipmentMember 2022-04-01 2022-12-31 0001538495 ETST:RxCompoundAndPeaksMember 2021-11-01 2021-11-03 0001538495 us-gaap:RestrictedStockMember 2022-10-01 2022-12-31 0001538495 us-gaap:RestrictedStockMember 2021-10-01 2021-12-31 0001538495 ETST:PurchaseAgreementMember 2022-11-08 0001538495 ETST:PurchaseAgreementMember 2022-11-07 2022-11-08 0001538495 ETST:PurchaseAgreementMember 2022-06-30 0001538495 srt:ChiefExecutiveOfficerMember 2022-12-31 0001538495 srt:ChiefFinancialOfficerMember 2022-12-31 iso4217:USD shares iso4217:USD shares pure utr:sqft 0001538495 false --03-31 Q3 2023 10-Q true 2022-12-31 false 000-55000 EARTH SCIENCE TECH, INC. FL 80-0931484 8950 SW 74th CT Suite 101 Miami FL 33156 (786) 375-7281 Common Stock $0.001 par value ETST Yes Yes Non-accelerated Filer true false false 256695496 24188 26942 0 101404 24188 26942 397382 25000 98000 25000 17806 513188 50000 537376 76942 119331 202270 31750 158846 220000 150000 200000 50000 250000 50000 102956 106800 86183 311610 585886 585886 83475 14429 14429 326838 326838 30000 10359 110363 1895 27500 344 59558 1408038 1882355 0.001 0.001 750000000 750000000 257964406 257964406 53851966 53851966 257966 53853 0.001 1000000 1000000 1000 29106164 28264452 -30265697 -30123718 -900567 -1805413 537376 76942 2533 3997 2533 13942 825 2467 825 7544 1708 1530 1708 6398 9654 30846 86173 46058 4500 5599 61526 161540 99035 22233 5165 31433 6065 -1712 4944 4944 4200 4200 512725 8297 18497 7267 49983 102481 819068 165081 -48275 -100951 -817360 -158683 166037 724062 3408930 18321 2452 29565 8040 9289 32203 1361 4068 1361 4068 1104 977 995 5929 1995 146739 -14097 687464 3362624 98464 -115048 -129896 3203941 98464 -115048 -129896 3203941 52851966 52853 28245452 -29977989 -1679684 500000 500 9500 10000 -115048 -115048 53351966 53353 28254952 -30093037 -1784732 500000 500 9500 10000 -30681 -30681 53851966 53853 28264452 -30123718 -1805413 -154682 -154682 53851966 53853 28264452 -30278400 -1960095 1700000 1700 1700 3500000 3500 3500 1000000 1000 -73678 -73678 59051966 59053 1000000 1000 28264452 -30352078 -2027573 62600000 62600 253900 316500 136312440 136312 587812 724124 -12084 -12083 30217 98464 98464 257964406 257965 1000000 1000 29106164 -30265697 -900567 -129896 3203941 -6691 -565663 18761 -724124 -6644 397039 3408637 -300780 127638 -669254 -44962 1712 1712 316500 38175 350000 666500 38175 -2754 -5075 26942 16161 24188 10586 <p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zQ1IPMwSvYV9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 — <span id="xdx_825_zVLN1H2X16pk">Organization and Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earth Science Tech, Inc. (“ETST” or the “Company”) was incorporated under the laws of the State of Nevada on April 23, 2010, subsequently changed to the State of Florida on June 27, 2022. As of November 8, 2022, the Company is a holding entity set to acquire companies with its current focus in the health and wellness industry. The Company is presently in compounding pharmaceuticals and telemedicine through its wholly owned subsidiaries RxCompoundStore.com, LLC. (“RxCompound”), Peaks Curative, LLC. (“Peaks”), and Earth Science Foundation, Inc. (“ESF”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">RxCompound </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is a compounding pharmacy that has historically focused on men’s health, specifically medical products directed at ED such as Tadalafil, and Sildenafil Citrate (the generic names for Cialis and Viagra, respectively) and longevity. Currently licensed to dispense in the state of Florida, New York, New Jersey, Delaware, Colorado, Rhode Island, and Arizona. RxCompound is in the application process to obtain licenses in the remaining states in which it is not yet licensed to dispense prescriptions. Furthermore, RxCompound recently obtained its hazardous room to compound hormonal creams within the month of December 2022 and is anticipated to have its sterile compounding room operational early 2023 to provide sterile products for injection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Peaks </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is the telemedicine referral site facilitating asynchronous consultations for branded compound medications prepared at RxCompound. Peaks is currently positioned to prescribe to all 50 states utilizing Smart Doctors consultation services, but only able to fulfill prescriptions within RxCompound’s licensed states. Peaks will be able to fulfill more states as RxCompound obtains dispensing licenses in additional states. Patients who order Peaks via monthly subscription will be automatically enrolled into Peaks’ Loyalty Program. As a member of the loyalty program, members will receive credit to cover the costs on their Peaks facilitated online doctor consultations. The Peaks membership enrollment will occur automatically once becoming a monthly subscriber and automatically renewed at the time of the prescription renewal order. At the time of the renewal order, credits will be applied to cover the Peaks facilitated online doctor consultation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peaks’ strategy has been to launch the website within three phases to insure efficiency and proper performance. Peaks launched its first Phase, Phase I, in the month of June 2022, offering one product, Tadalafil in a gummy form within 3 different dosages and quantity offerings. After months of feedback, successful orders and refills, Peaks commenced its Phase II website upgrade. Phase II will enhance the patient experience as well as offering Tadalafil in the form of gummies and tablets (generic Cialis), and Sildenafil in the form of capsules and tablets (generic Viagra) all in three different dosages and quantity offerings. Once Phase II has been completed, Peaks plans to execute a marketing campaign within the RxCompound dispensing states to increase brand exposure and sales leading to Phase III. Phase III includes over the counter (“OTC”) (non-prescription) products such as supplements and topicals. The OTC products will be custom manufactured or fulfilled through partnered companies under Peaks brand and offered worldwide.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ESF is a favored entity of ETST, effectively being a non-profit organization that was incorporated on February 11, 2019, and is structured to accept grants and donations to help those in need of assistance in paying for prescription.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zUEHAtLTmtC4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 — <span id="xdx_82F_zbUpeONslQQa">Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z8ERN3MKMXb5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zcLQ8MSN37Bi">Basis of presentation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s accounting policies used in the presentation of the accompanying consolidated financial statements conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zhyY4QOwD4T6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_z4wOYFdUwH39">Principles of consolidation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries Peaks and ESF. The Company’s acquisition of RxCompound was consummated on November 8, 2022, along with Peaks; however, RxCompound completed its PCAOB audit after the fiscal quarter that subsequently to period ended December 31, 2022, completed on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany balances and transactions have been eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zfepdV5WC0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_ztU3YgGLCekk">Use of estimates and assumptions</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change since there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zYGEDaQbc4F4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_z4ioKlfqtmY2">Carrying value, recoverability, and impairment of long-lived assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC’) 360 to evaluate its long-lived assets. The Company’s long-lived assets, which include property and equipment and a patent are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. Impairment of assets, if any, are included in operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjYLEnoYDZW4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zIsUlGqypjM7">Cash and cash equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with a maturity of three months or less to be cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--RelatedPartiesPolicyTextBlock_zVjBwMuGgaO8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zgC27AfRj8k8">Related parties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 850 for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to this ASC related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zpJx0rHDH3j2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zNMMLhXZywBc">Commitments and contingencies</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 450 to account for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. This may result in contingent liabilities that are required to be accrued or disclosed in the financial statements. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zqKvlEkTjC6c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zJbnydVRFpK7">Revenue recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows and implements ASC 606, Revenue from Contracts with Customers for revenue recognition. Although the new revenue standard is expected to have an immaterial effect, if any, on the Company’s ongoing net income, management did implement changes to the Company’s processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue from product sales or services rendered when control of the promised goods are transferred to the company’s clients in an amount that reflects the consideration to which management expects to be entitled in exchange for those goods and services. To achieve this core principle, management applies the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zqtd6yDMr8Fh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zrO90Ng551q1">Inventories</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not hold any inventories during the period ended December 31, 2022. During the Period ended December 31, 2022, the Company’s operating entity Peaks fulfilled its sales directly through RxCompound, owned by the Company, but did not complete its PCAOB audit during the period ended December 31, 2022. RxCompound completed its PCAOB audit on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events). The Company will have its inventories stated at the lower of cost or market using the first in, first out (FIFO) method after the period ended December 31, 2022. A reserve will be established if necessary to reduce excess or obsolete inventories to their realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--CostOfSalesPolicyTextBlock_z2hrodYdLXC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zWXO5ABX42h2">Cost of Sales</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components of costs of sales include product and shipping costs to customers and any inventory adjustments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zmGB3QtpDGx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zxLpyUzAvag">Shipping and Handling Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts shipping and handling costs to customers as cost of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNfq737Xtk9e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zWBxOn9S2NI2">Research and development</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs are expensed as incurred. The Company’s research and development expenses relate to its engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zlNkxva9dq01" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zAqogo6qRGld">Income taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740 in accounting for income taxes. Deferred tax assets and liabilities are determined based on the estimated future tax effects of net operating loss carry forwards and temporary differences between the tax bases of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records a valuation allowance for its deferred tax assets when management concludes that it is not more likely those assets will be recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20220401__20221231_zyGZ8mDzqIsj" title="Likelihood income tax percentage">greater than 50% likelihood</span> of being realized upon ultimate settlement. As of December 31, 2021, the Company has <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zNB3mL2uWRde" title="Unrecognized tax benefits">no</span>t recorded any unrecognized tax benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest and penalties related to liabilities for uncertain tax positions will be charged to interest and operating expenses, respectively. The Company has net operating loss carryforwards (NOL) for income tax purposes of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20221231_zg61p7xgqhuf" title="Net operating loss carryforwards">6,150,613</span>. This loss is allowed to be offset against future income until <span id="xdx_90A_ecustom--NetOperatingLossCarryForwardsExpirationDate_c20220401__20221231_z6gTlN0styKd" title="Net operating loss carry forwards expiration date">the year 2039 when the NOL’s will expire</span>. The tax benefits relating to all timing differences have been fully reserved for in the valuation allowance account due to the substantial losses incurred through September 30, 2022. There was <span id="xdx_90E_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_do_c20220401__20221231_zmQgqLi4aIfh" title="Valuation allowance"><span id="xdx_905_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_do_c20210401__20211231_zbZ8aIJXoVsc" title="Valuation allowance">no</span></span> change in the valuation allowance for the periods ended December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal Revenue Code Section 382 (“Section 382”) imposes limitations on the availability of a company’s net operating losses after certain ownership changes occur. The Section 382 limitation is based upon certain conclusions pertaining to the dates of ownership changes and the value of the Company on the dates of the ownership changes. It was determined that an ownership change occurred in October 2013 and March 2014. The amount of the Company’s net operating losses incurred prior to the ownership changes are limited based on the value of the Company on the date of the ownership change. Management has not determined the amount of net operating losses generated prior to the ownership change available to offset taxable income subsequent to the ownership change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zVwl8owYujLl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_z8HwmWoBe8n9">Net loss per common share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 260 to account for earnings per share. Basic earnings per common share calculations are determined by dividing net results from operations by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net results from operations by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company has <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220401__20221231_zh3p9JJ0BwBf" title="Antidilutive securities">no</span> warrants that are anti-dilutive and not included in the calculation of diluted loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--CashFlowsReportingPolicyTextBlock_zWDszfh18RQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zoxyoYLZmJi2">Cash flows reporting</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 230 to report cash flows. This standard classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by this standard to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports separately information about investing and financing activities not resulting in cash receipts or payments in the period pursuant this standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW4aCgnDABEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_z1fDnJ7bZyO9">Stock based compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 718 in accounting for its stock-based compensation to employees. These standards state that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price of the Company’s common stock as of the date in which the obligation for payment of service is incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company accounts for transactions in which services are received from non-employees in exchange for equity instruments based on the fair value of the equity instrument exchanged in accordance with ASC 505-50.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzHUxa8Pcyrh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zUithr5ctzv6">Property and equipment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost net of accumulated depreciation. Depreciation is computed using the straight-line method based upon the estimated useful lives of the respective assets as follows:</span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zuvZsrFtMP81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zPmGZJtMaSB2" style="display: none">Schedule of Property Plant and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements </span></td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentAdditionalDisclosures_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKKnJTsm2ln1" title="Estimated useful lives disclosures">Shorter of useful life or term of lease</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signage </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SignageMember_zOKFsQuAVVI9" title="Estimated useful lives">5 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zi4nKZRxt0A" title="Estimated useful lives">5 years</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zbzNZWg2AJWk" title="Estimated useful lives">5 years</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr> </table> <p id="xdx_8A9_zQ23FP5WZYB7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from accounts and any resulting gains or losses are included in operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHGEXlzDWNw6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_z6k6VeynnKr2">Recently issued accounting pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, <i>Classification of Certain Cash Receipts and Cash Payments</i>. The new standard will change the classification of certain cash payments and receipts within the cash flow statement. Specifically, payments for debt prepayment or debt extinguishment costs, including third-party costs, premiums paid, and other fees paid to lenders that are directly related to the debt prepayment or debt extinguishment, excluding accrued interest, will now be classified as financing activities. Previously, these payments were classified as operating expenses. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019, with early adoption permitted, and will be applied retrospectively. The Company does not expect that the adoption of this new standard will have a material impact on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases</i>. This ASU requires lessees to recognize most leases on their balance sheets related to the rights and obligations created by those leases. The ASU also requires additional qualitative and quantitative disclosures related to the nature, timing and uncertainty of cash flows arising from leases. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2016, the FASB issued Accounting Standards Update No. 2016-09, <i>Compensation – Stock Compensation</i>. The new standard modified several aspects of the accounting and reporting for employee share- based payments and related tax accounting impacts, including the presentation in the statements of operations and cash flows of certain tax benefits or deficiencies and employee tax withholdings, as well as the accounting for award forfeitures over the vesting period. The new standard was effective for the Company on April 1, 2017. The Company does not believe that the adoption of this new standard will have a material effect on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles-Goodwill and Other, which simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. Instead, if “the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.” The guidance is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All other newly issued accounting pronouncements not yet effective have been deemed either immaterial or not applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zGttyf9WHEcj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zw3FfcRZQDgd">Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s balance of intangible assets on the condensed consolidated balance sheet net of accumulated amortizations $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231_z5BkUjeC84ik" title="Intangible assets">17,806</span> and $<span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20211231_zhgAMv9IVeP4" title="Intangible assets">0</span> as of December 31, 2022, and December 31, 2021, from its Peaks telemedicine web platform.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zTyT6OulK2hl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zLg3XZGjvDZ2">Reclassification</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts from the prior period have been reclassified to conform to the current period presentation.</span></p> <p id="xdx_857_zRggwKVBFmij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z8ERN3MKMXb5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zcLQ8MSN37Bi">Basis of presentation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s accounting policies used in the presentation of the accompanying consolidated financial statements conform to accounting principles generally accepted in the United States of America (“US GAAP”) and have been consistently applied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zhyY4QOwD4T6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_z4wOYFdUwH39">Principles of consolidation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries Peaks and ESF. The Company’s acquisition of RxCompound was consummated on November 8, 2022, along with Peaks; however, RxCompound completed its PCAOB audit after the fiscal quarter that subsequently to period ended December 31, 2022, completed on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany balances and transactions have been eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zfepdV5WC0a2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_ztU3YgGLCekk">Use of estimates and assumptions</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change since there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zYGEDaQbc4F4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_z4ioKlfqtmY2">Carrying value, recoverability, and impairment of long-lived assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC’) 360 to evaluate its long-lived assets. The Company’s long-lived assets, which include property and equipment and a patent are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes. The Company evaluates assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events. Impairment of assets, if any, are included in operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjYLEnoYDZW4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zIsUlGqypjM7">Cash and cash equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with a maturity of three months or less to be cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--RelatedPartiesPolicyTextBlock_zVjBwMuGgaO8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zgC27AfRj8k8">Related parties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 850 for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to this ASC related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zpJx0rHDH3j2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zNMMLhXZywBc">Commitments and contingencies</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 450 to account for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. This may result in contingent liabilities that are required to be accrued or disclosed in the financial statements. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zqKvlEkTjC6c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zJbnydVRFpK7">Revenue recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows and implements ASC 606, Revenue from Contracts with Customers for revenue recognition. Although the new revenue standard is expected to have an immaterial effect, if any, on the Company’s ongoing net income, management did implement changes to the Company’s processes related to revenue recognition and the control activities within them. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue from product sales or services rendered when control of the promised goods are transferred to the company’s clients in an amount that reflects the consideration to which management expects to be entitled in exchange for those goods and services. To achieve this core principle, management applies the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zqtd6yDMr8Fh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zrO90Ng551q1">Inventories</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not hold any inventories during the period ended December 31, 2022. During the Period ended December 31, 2022, the Company’s operating entity Peaks fulfilled its sales directly through RxCompound, owned by the Company, but did not complete its PCAOB audit during the period ended December 31, 2022. RxCompound completed its PCAOB audit on February 3, 2023, (see Note 4, Related Party Balance and Transactions and Note 8, Subsequent Events). The Company will have its inventories stated at the lower of cost or market using the first in, first out (FIFO) method after the period ended December 31, 2022. A reserve will be established if necessary to reduce excess or obsolete inventories to their realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--CostOfSalesPolicyTextBlock_z2hrodYdLXC8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zWXO5ABX42h2">Cost of Sales</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Components of costs of sales include product and shipping costs to customers and any inventory adjustments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zmGB3QtpDGx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zxLpyUzAvag">Shipping and Handling Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts shipping and handling costs to customers as cost of revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNfq737Xtk9e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zWBxOn9S2NI2">Research and development</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs are expensed as incurred. The Company’s research and development expenses relate to its engineering activities, which consist of the design and development of new products for specific customers, as well as the design and engineering of new or redesigned products for the industry in general.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zlNkxva9dq01" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zAqogo6qRGld">Income taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 740 in accounting for income taxes. Deferred tax assets and liabilities are determined based on the estimated future tax effects of net operating loss carry forwards and temporary differences between the tax bases of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records a valuation allowance for its deferred tax assets when management concludes that it is not more likely those assets will be recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a <span id="xdx_900_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20220401__20221231_zyGZ8mDzqIsj" title="Likelihood income tax percentage">greater than 50% likelihood</span> of being realized upon ultimate settlement. As of December 31, 2021, the Company has <span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zNB3mL2uWRde" title="Unrecognized tax benefits">no</span>t recorded any unrecognized tax benefits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest and penalties related to liabilities for uncertain tax positions will be charged to interest and operating expenses, respectively. The Company has net operating loss carryforwards (NOL) for income tax purposes of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_iI_c20221231_zg61p7xgqhuf" title="Net operating loss carryforwards">6,150,613</span>. This loss is allowed to be offset against future income until <span id="xdx_90A_ecustom--NetOperatingLossCarryForwardsExpirationDate_c20220401__20221231_z6gTlN0styKd" title="Net operating loss carry forwards expiration date">the year 2039 when the NOL’s will expire</span>. The tax benefits relating to all timing differences have been fully reserved for in the valuation allowance account due to the substantial losses incurred through September 30, 2022. There was <span id="xdx_90E_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_do_c20220401__20221231_zmQgqLi4aIfh" title="Valuation allowance"><span id="xdx_905_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_do_c20210401__20211231_zbZ8aIJXoVsc" title="Valuation allowance">no</span></span> change in the valuation allowance for the periods ended December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal Revenue Code Section 382 (“Section 382”) imposes limitations on the availability of a company’s net operating losses after certain ownership changes occur. The Section 382 limitation is based upon certain conclusions pertaining to the dates of ownership changes and the value of the Company on the dates of the ownership changes. It was determined that an ownership change occurred in October 2013 and March 2014. The amount of the Company’s net operating losses incurred prior to the ownership changes are limited based on the value of the Company on the date of the ownership change. Management has not determined the amount of net operating losses generated prior to the ownership change available to offset taxable income subsequent to the ownership change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50% likelihood 0 6150613 the year 2039 when the NOL’s will expire 0 0 <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zVwl8owYujLl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_z8HwmWoBe8n9">Net loss per common share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 260 to account for earnings per share. Basic earnings per common share calculations are determined by dividing net results from operations by the weighted average number of shares of common stock outstanding during the year. Diluted loss per common share calculations are determined by dividing net results from operations by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company has <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220401__20221231_zh3p9JJ0BwBf" title="Antidilutive securities">no</span> warrants that are anti-dilutive and not included in the calculation of diluted loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 <p id="xdx_847_ecustom--CashFlowsReportingPolicyTextBlock_zWDszfh18RQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zoxyoYLZmJi2">Cash flows reporting</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 230 to report cash flows. This standard classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by this standard to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports separately information about investing and financing activities not resulting in cash receipts or payments in the period pursuant this standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zW4aCgnDABEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_z1fDnJ7bZyO9">Stock based compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC 718 in accounting for its stock-based compensation to employees. These standards state that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price of the Company’s common stock as of the date in which the obligation for payment of service is incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company accounts for transactions in which services are received from non-employees in exchange for equity instruments based on the fair value of the equity instrument exchanged in accordance with ASC 505-50.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zzHUxa8Pcyrh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zUithr5ctzv6">Property and equipment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost net of accumulated depreciation. Depreciation is computed using the straight-line method based upon the estimated useful lives of the respective assets as follows:</span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zuvZsrFtMP81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zPmGZJtMaSB2" style="display: none">Schedule of Property Plant and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements </span></td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentAdditionalDisclosures_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKKnJTsm2ln1" title="Estimated useful lives disclosures">Shorter of useful life or term of lease</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signage </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SignageMember_zOKFsQuAVVI9" title="Estimated useful lives">5 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zi4nKZRxt0A" title="Estimated useful lives">5 years</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zbzNZWg2AJWk" title="Estimated useful lives">5 years</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr> </table> <p id="xdx_8A9_zQ23FP5WZYB7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from accounts and any resulting gains or losses are included in operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zuvZsrFtMP81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zPmGZJtMaSB2" style="display: none">Schedule of Property Plant and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements </span></td> <td style="width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentAdditionalDisclosures_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKKnJTsm2ln1" title="Estimated useful lives disclosures">Shorter of useful life or term of lease</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signage </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SignageMember_zOKFsQuAVVI9" title="Estimated useful lives">5 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zi4nKZRxt0A" title="Estimated useful lives">5 years</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20220401__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zbzNZWg2AJWk" title="Estimated useful lives">5 years</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr> </table> Shorter of useful life or term of lease P5Y P5Y P5Y <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHGEXlzDWNw6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_z6k6VeynnKr2">Recently issued accounting pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, <i>Classification of Certain Cash Receipts and Cash Payments</i>. The new standard will change the classification of certain cash payments and receipts within the cash flow statement. Specifically, payments for debt prepayment or debt extinguishment costs, including third-party costs, premiums paid, and other fees paid to lenders that are directly related to the debt prepayment or debt extinguishment, excluding accrued interest, will now be classified as financing activities. Previously, these payments were classified as operating expenses. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019, with early adoption permitted, and will be applied retrospectively. The Company does not expect that the adoption of this new standard will have a material impact on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases</i>. This ASU requires lessees to recognize most leases on their balance sheets related to the rights and obligations created by those leases. The ASU also requires additional qualitative and quantitative disclosures related to the nature, timing and uncertainty of cash flows arising from leases. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2016, the FASB issued Accounting Standards Update No. 2016-09, <i>Compensation – Stock Compensation</i>. The new standard modified several aspects of the accounting and reporting for employee share- based payments and related tax accounting impacts, including the presentation in the statements of operations and cash flows of certain tax benefits or deficiencies and employee tax withholdings, as well as the accounting for award forfeitures over the vesting period. The new standard was effective for the Company on April 1, 2017. The Company does not believe that the adoption of this new standard will have a material effect on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. This guidance will supersede Topic 605, Revenue Recognition, in addition to other industry-specific guidance, once effective. The new standard requires a company to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, as a revision to ASU 2014-09, which revised the effective date to fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted but not prior to periods beginning after December 15, 2016 (i.e., the original adoption date per ASU 2014-09). In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations, which clarifies certain aspects of the principal- versus-agent guidance, including how an entity should identify the unit of accounting for the principal versus agent evaluation and how it should apply the control principle to certain types of arrangements, such as service transactions. The amendments also reframe the indicators to focus on evidence that an entity is acting as a principal rather than as an agent. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies how an entity should evaluate the nature of its promise in granting a license of intellectual property, which will determine whether it recognizes revenue over time or at a point in time. The amendments also clarify when a promised good or service is separately identifiable (i.e., distinct within the context of the contract) and allow entities to disregard items that are immaterial in the context of a contract. The Company continues to assess the impact this new standard may have on its ongoing financial reporting. The Company has identified its revenue streams both by contract and product type and is assessing each for potential impacts. For the revenue streams assessed, the Company does not anticipate a material impact in the timing or amount of revenue recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles-Goodwill and Other, which simplifies the accounting for goodwill impairments by eliminating step 2 from the goodwill impairment test. Instead, if “the carrying amount of a reporting unit exceeds its fair value, an impairment loss shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.” The guidance is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on its Consolidated Financial Statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All other newly issued accounting pronouncements not yet effective have been deemed either immaterial or not applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zGttyf9WHEcj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zw3FfcRZQDgd">Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s balance of intangible assets on the condensed consolidated balance sheet net of accumulated amortizations $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20221231_z5BkUjeC84ik" title="Intangible assets">17,806</span> and $<span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20211231_zhgAMv9IVeP4" title="Intangible assets">0</span> as of December 31, 2022, and December 31, 2021, from its Peaks telemedicine web platform.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 17806 0 <p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zTyT6OulK2hl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zLg3XZGjvDZ2">Reclassification</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts from the prior period have been reclassified to conform to the current period presentation.</span></p> <p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zq8cKm2aHhx6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 — <span id="xdx_82A_zj1UPZSJWGW1">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. On December 31, 2022, the Company had negative working capital, an accumulated deficit of $<span id="xdx_904_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20221231_zYzrYI9PIg7j" title="Accumulated deficit">30,265,697</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company as of November 8, 2022, became a holding entity set to acquire companies with its recent two acquisitions, RxCompound and Peaks both operating in the health and wellness industry. The Company’s cash position may not be sufficient to pay its obligations and support the Company’s daily operations. Management intends to raise additional funds by way of a public or private offering. Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues may provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate sufficient revenues by acquiring companies and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -30265697 <p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zIDsYBWkR9td" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 - <span id="xdx_822_zQTLmoOjPE93">Related Party Balances and Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On November 8, 2022, the Company amended the Purchase Agreement for the Membership Units of the RxCompound and Peaks, dated November 3, 2021. Pursuant to the terms of the</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment</i><span style="background-color: white">, the parties modified the Purchase Price on the November 3, 2021, agreement such that the Company agreed to issue a cumulative total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20211101__20211103__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RxCompoundAndPeaksMember_zhgW0oQgkdPg" title="Issued cumulative shares">53,700,000</span> shares of its restricted Common Stock in exchange for all outstanding Membership Units of both RxCompound and Peaks, (</span>see Note 4, Related Party Balance and Transactions)<span style="background-color: white">.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On December 29, 2022, Peaks completed its PCAOB audit and RxCompound </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">completed its audit after the period ended December 31, 2022, on February 3, 2023, (see note 8 Subsequent Event).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> 53700000 <p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z0MI8KwFrxT5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_821_zIxftpheir34">Stockholders’ Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended December 31, 2022, and 2021, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20221001__20221231_zbGXiiU61Gt5" title="Issued shares">62,600,000</span> and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20211001__20211231_zqJUvsxZuMh3" title="Issued shares">0</span> restricted common shares for cash of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20221001__20221231_zQR5mAnMkXC3" title="Issued value">316,500</span> and $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20211001__20211231_zmrtc0DnNxe4" title="Issued value">0</span> respectively, (see ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS<b>)</b>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended December 31, 2022, and 2021, the Company issued <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesForDebtSettlement_c20221001__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zm40W0MLcSN8" title="Common stock debt settlements">136,312,440</span> and <span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesForDebtSettlement_c20211001__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zMYcpeYQ2mM4" title="Common stock debt settlements">0</span> restricted common shares for debt settlements at a fair value of $<span id="xdx_90D_ecustom--StockIssuedDuringPeriodValueForDebtSettlement_c20221001__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zW89ihnJoAr1" title="Common stock debt settlements">724,124</span> and $<span id="xdx_90F_ecustom--StockIssuedDuringPeriodValueForDebtSettlement_c20211001__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zrYrz0GuF8r3" title="Common stock debt settlements">0</span> respectively, (see RESULTS OF OPERATIONS and ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 62600000 0 316500 0 136312440 0 724124 0 <p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z3jH93aK0zP" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 — <span id="xdx_823_zNeOil0kNKLl">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Legal Proceedings</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt">The Company did not have any material legal proceedings during the period ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Lease Agreements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is presently located at RxCompound’s location at 8950 SW 74<sup>th</sup> Court Suite 101, Miami, FL, 33156 after the Purchase Agreement was consummated on November 8, 2022, (see Note 4, Related Party Balance and Transactions). RxCompound’s location sits in <span id="xdx_90B_eus-gaap--AreaOfLand_iI_uSquareFoot_c20221108__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zgFnATMRjWOj" title="Area of Land">1,900</span> sq ft composed of offices, cooking room, hazardous room, sterile compounding room, lobby, and storage. The lease requires monthly payments of $<span id="xdx_906_eus-gaap--OperatingLeasePayments_c20221107__20221108__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zxnfzep8Kbm7" title="Lease requires payments">7,057</span> for a term of 36-months plus the single lump sum payment of $<span id="xdx_904_ecustom--LumpSumPayment_iI_c20220630__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zVoUzblMvnBk" title="Lump sum payment">40,000</span> upon execution in June 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1900 7057 40000 <p id="xdx_80E_ecustom--BalanceSheetAndIncomeStatementFootnotesTextBlock_zCXTBkVdYF4g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 — <span id="xdx_828_zuMB4oNlcyLl">Balance Sheet and Income Statement Footnotes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A<b>c</b>counts receivable represent normal trade obligations from customers that are subject to normal trade collection terms, without discounts or rebates. If collection is expected in one year or less, they are classified as current assets. If not, they are presented as non-current assets. Notwithstanding these collections, the Company periodically evaluates the collectability of accounts receivable and considers the need to establish an allowance for doubtful debts based upon historical collection experience and specifically identifiable information about its customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses of $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zqy7kjeeiyDl" title="Accrued expenses">86,183</span> as of December 31, 2022, mainly represent $<span id="xdx_907_eus-gaap--AccruedPayrollTaxesCurrent_iI_c20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zTt4OyJn9HXe" title="Accrued payroll taxes">67,410</span> in accrued payroll for the company’s CEO and CFO, and the remainder for accrued interest on Notes Payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5.4pt; text-align: justify; text-indent: -5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses were $<span id="xdx_902_eus-gaap--GeneralAndAdministrativeExpense_c20221001__20221231_zJIQkZTs8R6d" title="General and administrative expenses">5,599</span> and $<span id="xdx_908_eus-gaap--GeneralAndAdministrativeExpense_c20211001__20211231_zLc8AIC42Yuc" title="General and administrative expenses">61,526</span> for December 31, 2022, and 2021 respectively. For the three months ended December 31, 2022, $<span id="xdx_904_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20221001__20221231_zjZrOiNafc4d" title="Employee compensation">2,236</span> was employee compensation, $<span id="xdx_900_ecustom--MiscellaneousExpenses_c20221001__20221231_zZv8EXB2YYA3" title="Miscellaneous expenses">1,032</span> internet and computer expenses, and the remainder was on miscellaneous expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional fees were $<span id="xdx_902_eus-gaap--ProfessionalFees_c20221001__20221231_zvhby3QRN4S8" title="Professional fees">22,233</span> for the three months ended December 31, 2022. For the three months ended December 31, 2022, there were $<span id="xdx_90C_ecustom--AuditorFees_c20221001__20221231_zdlQotDJlAek" title="Auditor fees">9,500</span> in auditor fees, $<span id="xdx_90D_ecustom--ConsultingFees_c20221001__20221231_zLrrMKTfshTf" title="Consulting fees">6,200</span> in consulting fees, $<span id="xdx_90A_eus-gaap--LegalFees_c20221001__20221231_z0vla1ufiWjg" title="Legal fees">5,000</span> in SEC legal fees and the remainder were miscellaneous fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income was $<span id="xdx_90C_eus-gaap--NonoperatingIncomeExpense_c20221001__20221231_zjN79Bjpml4b" title="Other income">146,739</span> for the three months ended December 31, 2022, from a debt settlement, (see November 8, 2022, 8-K filing).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense was $<span id="xdx_900_eus-gaap--InterestExpenseDebt_iN_di_c20221001__20221231_zPin0X9bkfeg" title="Interest expense">(18,321)</span> and $<span id="xdx_90D_eus-gaap--InterestExpenseDebt_iN_di_c20211001__20211231_ze3UKtFZXBhk" title="Interest expense">(2,452)</span> for three months ended December 31, 2022, and 2021. Interest expense for three months ended December 31, 2022, was mainly due to Convertible Notes II and I (“VCAMJI Irrevocable Trust Convertible Note I” and VCAMJI Irrevocable Trust Note II”) and Revolving Promissory Note (“Issa El-Chelkh Revolving Promissory Note”), (see Item 2, Liquidity and Capital Resources).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 86183 67410 5599 61526 2236 1032 22233 9500 6200 5000 146739 18321 2452 <p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zuqa6Kh038Wf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 — <span id="xdx_824_z6bVMc95oPra">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2023, the Company received RxCompound’s audited financials pursuant to the previously announced Purchase and Sale Agreement dated November 8, 2022, and for the purposes set forth therein, the seller of RxCompound entered into a Purchase and Sale Agreement, pursuant to which the Company agreed to acquire the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="color: #242424; background-color: white">The Company received an email on February 9, 2023 from </span><span style="background-color: white">the Autorité des Marchés Financiers (“the AMF”) with a complaint, in French dated January 23, 2023. The Complaint alleges that the Company's former CEO, Dr. Michele Aube, improperly raised capital for the Company and is claiming Forty Thousand Dollars in damages. Dr. Aube resigned in 2019. The Company has retained legal counsel in Quebec and will vigorously defend this claim.</span></p> EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 37 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 38 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 95 171 1 false 21 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://earthsciencetech.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://earthsciencetech.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://earthsciencetech.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://earthsciencetech.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity Sheet http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity Consolidated Statements of Stockholders' (Deficit) Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://earthsciencetech.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Nature of Operations Sheet http://earthsciencetech.com/role/OrganizationAndNatureOfOperations Organization and Nature of Operations Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://earthsciencetech.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://earthsciencetech.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Related Party Balances and Transactions Sheet http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactions Related Party Balances and Transactions Notes 10 false false R11.htm 00000011 - Disclosure - Stockholders??? Equity Sheet http://earthsciencetech.com/role/StockholdersEquity Stockholders??? Equity Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://earthsciencetech.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Balance Sheet and Income Statement Footnotes Notes http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotes Balance Sheet and Income Statement Footnotes Notes 13 false false R14.htm 00000014 - Disclosure - Subsequent Events Sheet http://earthsciencetech.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://earthsciencetech.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://earthsciencetech.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Schedule of Property Plant and Equipment (Details) Sheet http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails Schedule of Property Plant and Equipment (Details) Details 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesTables 18 false false R19.htm 00000019 - Disclosure - Going Concern (Details Narrative) Sheet http://earthsciencetech.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://earthsciencetech.com/role/GoingConcern 19 false false R20.htm 00000020 - Disclosure - Related Party Balances and Transactions (Details Narrative) Sheet http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative Related Party Balances and Transactions (Details Narrative) Details http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactions 20 false false R21.htm 00000021 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://earthsciencetech.com/role/StockholdersEquity 21 false false R22.htm 00000022 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://earthsciencetech.com/role/CommitmentsAndContingencies 22 false false R23.htm 00000023 - Disclosure - Balance Sheet and Income Statement Footnotes (Details Narrative) Notes http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative Balance Sheet and Income Statement Footnotes (Details Narrative) Details http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotes 23 false false All Reports Book All Reports form10-q.htm etst-20221231.xsd etst-20221231_cal.xml etst-20221231_def.xml etst-20221231_lab.xml etst-20221231_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 40 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 430, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 95, "dts": { "calculationLink": { "local": [ "etst-20221231_cal.xml" ] }, "definitionLink": { "local": [ "etst-20221231_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "etst-20221231_lab.xml" ] }, "presentationLink": { "local": [ "etst-20221231_pre.xml" ] }, "schema": { "local": [ "etst-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 275, "entityCount": 1, "hidden": { "http://earthsciencetech.com/20221231": 18, "http://fasb.org/us-gaap/2022": 160, "http://xbrl.sec.gov/dei/2022": 5, "total": 183 }, "keyCustom": 22, "keyStandard": 149, "memberCustom": 11, "memberStandard": 10, "nsprefix": "ETST", "nsuri": "http://earthsciencetech.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://earthsciencetech.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Related Party Balances and Transactions", "menuCat": "Notes", "order": "10", "role": "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactions", "shortName": "Related Party Balances and Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "11", "role": "http://earthsciencetech.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "12", "role": "http://earthsciencetech.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ETST:BalanceSheetAndIncomeStatementFootnotesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Balance Sheet and Income Statement Footnotes", "menuCat": "Notes", "order": "13", "role": "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotes", "shortName": "Balance Sheet and Income Statement Footnotes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ETST:BalanceSheetAndIncomeStatementFootnotesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "14", "role": "http://earthsciencetech.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "15", "role": "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "16", "role": "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-012022-12-31_us-gaap_LeaseholdImprovementsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentAdditionalDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Schedule of Property Plant and Equipment (Details)", "menuCat": "Details", "order": "17", "role": "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "shortName": "Schedule of Property Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-012022-12-31_us-gaap_LeaseholdImprovementsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentAdditionalDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "18", "role": "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Going Concern (Details Narrative)", "menuCat": "Details", "order": "19", "role": "http://earthsciencetech.com/role/GoingConcernDetailsNarrative", "shortName": "Going Concern (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://earthsciencetech.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Related Party Balances and Transactions (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative", "shortName": "Related Party Balances and Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-11-012021-11-03_custom_RxCompoundAndPeaksMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "21", "role": "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-11-08_custom_PurchaseAgreementMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unique": true, "unitRef": "SquareFoot", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Commitments and Contingencies (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-11-08_custom_PurchaseAgreementMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unique": true, "unitRef": "SquareFoot", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Balance Sheet and Income Statement Footnotes (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative", "shortName": "Balance Sheet and Income Statement Footnotes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ETST:BalanceSheetAndIncomeStatementFootnotesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:EmployeeBenefitsAndShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://earthsciencetech.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://earthsciencetech.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity", "menuCat": "Statements", "order": "5", "role": "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity", "shortName": "Consolidated Statements of Stockholders' (Deficit) Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://earthsciencetech.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-04-012021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Organization and Nature of Operations", "menuCat": "Notes", "order": "7", "role": "http://earthsciencetech.com/role/OrganizationAndNatureOfOperations", "shortName": "Organization and Nature of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Going Concern", "menuCat": "Notes", "order": "9", "role": "http://earthsciencetech.com/role/GoingConcern", "shortName": "Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 21, "tag": { "ETST_AccruedSettlementOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued Settlement [One Member]", "label": "Accrued Settlement [One Member]" } } }, "localname": "AccruedSettlementOneMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "ETST_AccruedSettlementTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued Settlement [Two Member]", "label": "Accrued Settlement [Two Member]" } } }, "localname": "AccruedSettlementTwoMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "ETST_AuditorFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Auditor fees.", "label": "Auditor fees" } } }, "localname": "AuditorFees", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ETST_BalanceSheetAndIncomeStatementFootnotesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Balance sheet and income statement footnotes [Text Block]", "label": "Balance Sheet and Income Statement Footnotes" } } }, "localname": "BalanceSheetAndIncomeStatementFootnotesTextBlock", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotes" ], "xbrltype": "textBlockItemType" }, "ETST_CashFlowsReportingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash flows reporting [Policy Text Block]", "label": "Cash flows reporting" } } }, "localname": "CashFlowsReportingPolicyTextBlock", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ETST_ConsultingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting fees.", "label": "Consulting fees" } } }, "localname": "ConsultingFees", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ETST_ConvertibleNoteFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note Four [Member]", "label": "Convertible Note Four [Member]" } } }, "localname": "ConvertibleNoteFourMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "ETST_ConvertibleNoteGHSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note GHS [Member]", "label": "Convertible Note G H S [Member]" } } }, "localname": "ConvertibleNoteGHSMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "ETST_ConvertibleNoteOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note [One Member]", "label": "Convertible Note [One Member]" } } }, "localname": "ConvertibleNoteOneMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "ETST_ConvertibleNoteThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note [Three Member]", "label": "Convertible Note [Three Member]" } } }, "localname": "ConvertibleNoteThreeMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "ETST_ConvertibleNoteTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note [Two Member]", "label": "Convertible Note [Two Member]" } } }, "localname": "ConvertibleNoteTwoMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "ETST_CostOfLegalProceedings": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of legal proceedings.", "label": "Cost of legal proceedings" } } }, "localname": "CostOfLegalProceedings", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ETST_DisclosureBalanceSheetAndIncomeStatementFootnotesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheet And Income Statement Footnotes" } } }, "localname": "DisclosureBalanceSheetAndIncomeStatementFootnotesAbstract", "nsuri": "http://earthsciencetech.com/20221231", "xbrltype": "stringItemType" }, "ETST_InterestIncomeExpenseBankLoan": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest income expense bank loan.", "label": "InterestIncomeExpenseBankLoan", "negatedLabel": "Interest SBA Loan" } } }, "localname": "InterestIncomeExpenseBankLoan", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ETST_InterestPayable": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest payable", "label": "Note Payable Interest" } } }, "localname": "InterestPayable", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "ETST_LoanAdvance": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loan advance.", "label": "Loan Advance" } } }, "localname": "LoanAdvance", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "ETST_LumpSumPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lump sum payment.", "label": "Lump sum payment" } } }, "localname": "LumpSumPayment", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ETST_MiscellaneousExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Miscellaneous expenses", "label": "Miscellaneous expenses" } } }, "localname": "MiscellaneousExpenses", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ETST_NetOperatingLossCarryForwardsExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating loss carry forwards expiration date.", "label": "Net operating loss carry forwards expiration date" } } }, "localname": "NetOperatingLossCarryForwardsExpirationDate", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "ETST_NotePayableInterest": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Note payable interest.", "label": "Note payable interest", "negatedLabel": "Note Payable Interest" } } }, "localname": "NotePayableInterest", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ETST_PeaksCurativeRetainedEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Peaks curative retained earnings.", "label": "Peaks Curative retained earnings" } } }, "localname": "PeaksCurativeRetainedEarnings", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "ETST_PrepaidAcquisitionCosts": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid acquisition costs.", "label": "Prepaid Acquisition Costs" } } }, "localname": "PrepaidAcquisitionCosts", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "ETST_ProceedsFromIntrinsicValueOfConvNotesaddtlPaidincapital": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of Conv Notes-Addtl Paid-in-Capital.", "label": "Intrinsic value of Conv Notes-Addtl Paid-in-Capital" } } }, "localname": "ProceedsFromIntrinsicValueOfConvNotesaddtlPaidincapital", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ETST_PromissoryNote": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Promissory note.", "label": "Promissory Note" } } }, "localname": "PromissoryNote", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "ETST_PromissoryNoteGHSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Note GHS [Member]", "label": "Promissory Note GHS [Member]" } } }, "localname": "PromissoryNoteGHSMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "ETST_PurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase agreement [Member]", "label": "Purchase Agreement [Member]" } } }, "localname": "PurchaseAgreementMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "ETST_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ETST_RxCompoundAndPeaksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rx Compound And Peaks [Member]", "label": "Rx Compound And Peaks [Member]" } } }, "localname": "RxCompoundAndPeaksMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ETST_ShortTermBankLoansAndNotesPayables": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "SBA Payable" } } }, "localname": "ShortTermBankLoansAndNotesPayables", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "ETST_SignageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Signage [Member]", "label": "Signage [Member]" } } }, "localname": "SignageMember", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ETST_StockIssuedDuringPeriodPreferredStockSharesOfficerCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period preferred stock shares officer compensation.", "label": "Preferred stock B issued for officer compensation, shares" } } }, "localname": "StockIssuedDuringPeriodPreferredStockSharesOfficerCompensation", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "ETST_StockIssuedDuringPeriodPreferredStockValueOfficerCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period preferred stockvalue officer compensation", "label": "Preferred stock B issued for officer compensation" } } }, "localname": "StockIssuedDuringPeriodPreferredStockValueOfficerCompensation", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "ETST_StockIssuedDuringPeriodSharesForDebtSettlement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares for debt settlement.", "label": "Common stock issued for debt settlement, shares", "verboseLabel": "Common stock debt settlements" } } }, "localname": "StockIssuedDuringPeriodSharesForDebtSettlement", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity", "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ETST_StockIssuedDuringPeriodValueForDebtSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value for debt settlement.", "label": "Common stock issued for debt settlement", "verboseLabel": "Common stock debt settlements" } } }, "localname": "StockIssuedDuringPeriodValueForDebtSettlement", "nsuri": "http://earthsciencetech.com/20221231", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity", "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r347", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://earthsciencetech.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r366", "r375" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r15", "r335" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r156", "r157" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable(net allowance of $0 and $101,404 respectively )" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative", "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll taxes" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r335" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r253", "r254", "r255", "r363", "r364", "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r103", "r158", "r161" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts receivable, allowance for credit loss, current" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of Land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r76", "r84", "r102", "r118", "r144", "r147", "r151", "r159", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r272", "r274", "r279", "r335", "r369", "r370", "r377" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r96", "r106", "r118", "r159", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r272", "r274", "r279", "r335", "r369", "r370", "r377" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r224", "r225", "r226", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r248", "r249", "r250", "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r40", "r99", "r324" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r36", "r40", "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash - End of period", "periodStartLabel": "Cash - Beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r36", "r71" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Decrease in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r21", "r80", "r87" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r57", "r166", "r167", "r320", "r368" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r58", "r321" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "verboseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r363", "r364", "r373" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r59" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r335" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, par value $0.001 per share, 750,000,000 shares authorized; 257,964,406 and 53,851,966 shares issued and outstanding as of December 31, 2022 and March 31, 2022 respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r69", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r27", "r118", "r159", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r279", "r369" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Sales" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r3", "r4", "r5", "r77", "r78", "r83", "r120", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r286", "r330", "r331", "r332", "r333", "r334", "r360" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r20", "r120", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r286", "r330", "r331", "r332", "r333", "r334", "r360" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DueFromRelatedPartiesNoncurrent": { "auth_ref": [ "r100", "r170", "r171", "r172", "r176", "r177", "r178", "r293", "r362" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date, which are usually due after one year (or one business cycle).", "label": "Due from RxCompound" } } }, "localname": "DueFromRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToAffiliateCurrent": { "auth_ref": [ "r2", "r72", "r91", "r362" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to RxCompoundStore.com, LLC." } } }, "localname": "DueToAffiliateCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r44", "r45" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net loss per common share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Employee compensation" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r59", "r94", "r110", "r111", "r112", "r121", "r122", "r123", "r125", "r130", "r132", "r136", "r160", "r209", "r253", "r254", "r255", "r268", "r269", "r277", "r280", "r281", "r282", "r283", "r284", "r285", "r289", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r52", "r300" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Telemedicine Platform", "verboseLabel": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r359" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative", "verboseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r50", "r51" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r26", "r118", "r144", "r146", "r150", "r152", "r159", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r279", "r329", "r369" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r53", "r56" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Carrying value, recoverability, and impairment of long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r24", "r75", "r81", "r90", "r144", "r146", "r150", "r152", "r313", "r329" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net Profit/(Loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r66", "r67" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Likelihood income tax percentage" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r119", "r131", "r132", "r143", "r261", "r270", "r271", "r314" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r109", "r259", "r260", "r263", "r264", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Decrease in accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase/Decrease in accrued settlement" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Increase in inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Decrease in other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Increase/Decrease in prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInTradingSecurities": { "auth_ref": [ "r35", "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of investment in debt and equity securities, measured at fair value with changes in fair value recognized in net income.", "label": "Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI", "negatedLabel": "Stock issued for debt settlement" } } }, "localname": "IncreaseDecreaseInTradingSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r31", "r192", "r195", "r333", "r334" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "negatedLabel": "Interest Expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r105", "r325", "r335" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r98", "r104", "r135", "r163", "r164", "r165", "r298", "r327" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r79", "r86", "r335", "r361", "r367", "r374" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 (Deficit) Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r19", "r97", "r118", "r159", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r273", "r274", "r275", "r279", "r335", "r369", "r377", "r378" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r3", "r77" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Revolving Promissory Note" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Expense" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.", "label": "PPP Loan" } } }, "localname": "LoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r29" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Marketing" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r115" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r115" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used in Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r36", "r37", "r39" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r25", "r39", "r82", "r89", "r95", "r107", "r108", "r112", "r118", "r124", "r126", "r127", "r128", "r129", "r131", "r132", "r133", "r144", "r146", "r150", "r152", "r159", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r278", "r279", "r329", "r369" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://earthsciencetech.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Profit/(Loss)", "totalLabel": "Net Profit/(Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows", "http://earthsciencetech.com/role/StatementsOfOperations", "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently issued accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r30" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Other income", "totalLabel": "Total other income (expenses)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Note Payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r14", "r73", "r362" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable - related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r358" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Compensation - officers" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r144", "r146", "r150", "r152", "r329" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r287", "r288" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Lease requires payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r70" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization and Nature of Operations" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/OrganizationAndNatureOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r101" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "totalLabel": "Total other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r114" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Income (Expenses)" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r196" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r335" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock B par value $0.001 per share 1,000,000 authorized and outstanding as of December 31, 2022" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r357" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r34" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r33" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r32" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Purchases of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r92", "r93" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditionalDisclosures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional information disclosed pertaining to property, plant and equipment.", "label": "Estimated useful lives disclosures" } } }, "localname": "PropertyPlantAndEquipmentAdditionalDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r55", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r113", "r162" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r221", "r292", "r293" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r221", "r292", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r290", "r291", "r293", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Balances and Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r61", "r85", "r318", "r319", "r335" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r94", "r121", "r122", "r123", "r125", "r130", "r132", "r160", "r253", "r254", "r255", "r268", "r269", "r277", "r315", "r317" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r141", "r142", "r145", "r148", "r149", "r153", "r154", "r155", "r218", "r219", "r299" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r220", "r328" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r63", "r64" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheetAndIncomeStatementFootnotesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r73", "r74" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r222", "r223", "r224", "r225", "r226", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r248", "r249", "r250", "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SettlementLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers.", "label": "Accrued settlement" } } }, "localname": "SettlementLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r38" ], "calculation": { "http://earthsciencetech.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Officer compensation stock" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r224", "r225", "r226", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r248", "r249", "r250", "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r227", "r246", "r247", "r248", "r249", "r252", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r13", "r88" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "SBA EDIL Loan" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r43", "r116" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r59", "r94", "r110", "r111", "r112", "r121", "r122", "r123", "r125", "r130", "r132", "r136", "r160", "r209", "r253", "r254", "r255", "r268", "r269", "r277", "r280", "r281", "r282", "r283", "r284", "r285", "r289", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r121", "r122", "r123", "r136", "r299" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r22", "r59", "r60", "r61", "r189" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Common stock issued for Conversion on Note, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r7", "r59", "r61" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued for cash, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r59", "r61" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Issued cumulative shares", "verboseLabel": "Issued shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative", "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Common stock issued for officer compensation, shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r23", "r59", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common stock issued for Conversion on Note" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r23", "r59", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Peaks common units" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Common stock issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r6", "r7", "r59", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common stock issued for cash" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r6", "r7", "r59", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Issued value" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Common stock issued for officer compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r49", "r335", "r361", "r367", "r374" ], "calculation": { "http://earthsciencetech.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 (Deficit)Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets", "http://earthsciencetech.com/role/StatementsOfStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 (Deficit) Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r62", "r117", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r276" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r258", "r262" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r46", "r47", "r48", "r137", "r138", "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates and assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r265" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://earthsciencetech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r336": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r337": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r339": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r341": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r342": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r343": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r344": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r345": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r346": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r347": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r348": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r349": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r351": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r352": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r353": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r354": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r355": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 41 0001493152-23-004324-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-004324-xbrl.zip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